Processing 00000000.tx.1: Rockefeller University Press, 0022-1007 $8.00 JEM, Volume 201, Number 12, 1869-1873 This Article Abstract PDF (Full Text) Alert me when this article is cited Citation Map Services Alert me to new content in the JEM Download to citation manager Cited by other online articles Google Scholar Articles by Boyce, J. 

Phrase: "Rockefeller University Press,"

Phrase: "0022-1007 $8.00 JEM,"

Phrase: "Volume 201,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "1869-1873"

Phrase: "This Article Abstract PDF (Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: ")"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205314:New [Temporal Concept]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "in the JEM Download"

Phrase: "to citation manager"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0335141:manager [Professional or Occupational Group]
   861   C1546507:Manager [Idea or Concept]

Phrase: "Cited by other online articles Google Scholar Articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0684017:scholar [Professional or Occupational Group]
   711   C1706852:Article [Intellectual Product]

Phrase: "by Boyce,"

Phrase: "J."
Processing 00000000.tx.2: A. 

Phrase: "A."
Processing 00000000.tx.3: Articles by Austen, K. 

Phrase: "Articles by Austen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.4: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.5: Articles citing this Article PubMed PubMed Citation Articles by Boyce, J. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Boyce,"

Phrase: "J."
Processing 00000000.tx.6: A. 

Phrase: "A."
Processing 00000000.tx.7: Articles by Austen, K. 

Phrase: "Articles by Austen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.8: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.9: COMMENTARY No audible wheezing : nuggets and conundrums from mouse asthma models Joshua A. 

Phrase: "COMMENTARY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282411:Commentary [Intellectual Product]

Phrase: "No audible wheezing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043144:Wheezing [Sign or Symptom]

Phrase: ":"

Phrase: "nuggets"

Phrase: "and"

Phrase: "conundrums from mouse asthma"

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "Joshua A."
Processing 00000000.tx.10: Boyce and K. 

Phrase: "Boyce"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.11: Frank Austen J.A.B. and K.F.A. are at Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115. 

Phrase: "Frank Austen J.A.B."

Phrase: "and"

Phrase: "K.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "A."

Phrase: "are at Brigham and Women's Hospital,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   753   C0043210:Women [Population Group]
   753   C1510665:Hospital [Qualitative Concept]
   753   C1551058:Are [Quantitative Concept]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115."
Processing 00000000.tx.12: CORRESPONDENCE K.F.A.: 

Phrase: "CORRESPONDENCE K.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "A."

Phrase: ":"
Processing 00000000.tx.13: fausten{at}rics.bwh.harvard.edu OR J.A.B.: 

Phrase: "fausten{at}rics.bwh.harvard.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "OR"

Phrase: "J.A.B."

Phrase: ":"
Processing 00000000.tx.14: Jboyce{at}rics.bwh.harvard.edu Mouse models of T helper type 2 (Th2) cellbiased pulmonary inflammation have elucidated mechanisms of sensitization, cell traffic, and induced airway hyperresponsiveness (AHR). 

Phrase: "Jboyce{at}rics.bwh.harvard.edu Mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]

Phrase: "models of T helper type 2 (Th2) cellbiased pulmonary inflammation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0032285:Pulmonary Inflammation [Disease or Syndrome]
   764   C0441730:Type 2 [Classification]
   762   C0333346:Inflammation type [Classification]
   742   C0021368:Inflammation [Pathologic Function]
   742   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C2707265:Pulmonary [Clinical Attribute]
   742   C2709248:Pulmonary [Qualitative Concept]
   742   C3161035:Model [Intellectual Product]

Phrase: "have"

Phrase: "elucidated mechanisms of sensitization,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "cell traffic,"

Phrase: "and"

Phrase: "induced airway hyperresponsiveness (AHR)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.15: Nonetheless, most mice lack intrinsic AHR, a central property of human asthma, and disparities persist regarding the contributions of eosinophils and mast cells and the sensitivity to induced AHR in the commonly used mouse strains. 

Phrase: "Nonetheless,"

Phrase: "most mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "intrinsic AHR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "a central property of human asthma,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0871161:Property [Qualitative Concept]
   753   C1882134:Property [Conceptual Entity]
   753   C2347695:Property [Entity]

Phrase: "and"

Phrase: "disparities"

Phrase: "persist"

Phrase: "regarding"

Phrase: "the contributions of eosinophils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the sensitivity to induced AHR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "in the commonly used mouse strains."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C1513684:Mouse Strains [Mammal]
   812   C0080194:Strains [Injury or Poisoning]
   812   C0456178:strains [Intellectual Product]
   779 E C1518614:Strain [Organism]
   779 E C2987481:Strain [Mental Process]
Processing 00000000.tx.16: We suggest that these discordances, reflecting methodological and genetic differences, may be informative for understanding heterogeneity of human asthma. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these discordances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C3639994:Discordant [Conceptual Entity]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "methodological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0969625:methodology [Intellectual Product]
   928   C3266812:Methodology [Idea or Concept]

Phrase: "and"

Phrase: "genetic differences,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "informative for understanding heterogeneity of human asthma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.17: Human bronchial asthma is heterogeneous in terms of severity, genetics, and in all likelihood pathophysiology. 

Phrase: "Human bronchial asthma"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0004096:Bronchial Asthma [Disease or Syndrome]
           Asthma
   901   C1869116:ASTHMA, BRONCHIAL [Finding]
   827   C0205039:Bronchial [Body Part, Organ, or Organ Component]
   827   C1442216:Bronchial [Body Part, Organ, or Organ Component]
   827   C2984299:Asthma [Functional Concept]

Phrase: "is"

Phrase: "heterogeneous in terms of severity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "and in all likelihood pathophysiology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031847:pathophysiology [Functional Concept]
   760   C0033204:Likelihood [Quantitative Concept]
   760   C0277785:Pathophysiology [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.18: It is characterized physiologically by persistent AHR to pharmacologic bronchoconstrictors, and by variable, episodic intrathoracic airflow obstruction that is at least partly reversible with agonists of the 2 adrenergic receptor. 

Phrase: "It"

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "physiologically by persistent AHR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0178987:Airway, NOS [Medical Device]
   760   C0205322:Persistent [Temporal Concept]
   760   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "to pharmacologic bronchoconstrictors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079044:Bronchoconstrictors [Pharmacologic Substance]

Phrase: "and by variable,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439828:Variable [Qualitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "episodic intrathoracic airflow obstruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0028778:Obstruction [Pathologic Function]
   812   C1882136:OBSTRUCTION [Phenomenon or Process]

Phrase: "that"

Phrase: "is at least partly reversible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205343:Reversible [Functional Concept]

Phrase: "with agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "of the 2 adrenergic receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034783:Adrenergic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0599756:adrenergic [Functional Concept]
Processing 00000000.tx.19: Asthma is also associated with Th2-like bronchial wall inflammation, regardless of whether individuals have allergen-specific IgE. 

Phrase: "Asthma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004096:Asthma [Disease or Syndrome]
  1000   C2984299:Asthma [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "associated with Th2-"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "like bronchial wall inflammation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021368:Inflammation [Pathologic Function]
   734   C0506973:Bronchial wall [Body Part, Organ, or Organ Component]
   734   C1180039:Bronchial wall [Body Part, Organ, or Organ Component]

Phrase: "regardless of"

Phrase: "whether"

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "have"

Phrase: "allergen-specific IgE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443736:Allergen specific IgE [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.20: Lymphocytes producing Th2-like cytokines (interleukin [IL] 4, 5, 9, and 13) (1), eosinophils, and mast cells (2) infiltrate the mucosal epithelium and submucosa. 

Phrase: "Lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "producing"

Phrase: "Th2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441730:Type 2 [Classification]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "like cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(interleukin [IL] 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334119:INTERLEUKIN 4 [Gene or Genome]
  1000   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9,"

Phrase: "and"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "eosinophils,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014467:Eosinophils [Cell]
  1000   C0200638:Eosinophils [Laboratory Procedure]
   916 E C0333930:Eosinophilic [Functional Concept]
   893 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   893 E C1306759:Eosinophilia [Disease or Syndrome]
   893 E C1636667:Eosinophilia [Disease or Syndrome]
   893 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(1), eosinophils, and mast cells (2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "infiltrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332448:Infiltrate [Pathologic Function]
  1000   C1546677:Infiltrate [Intellectual Product]
  1000   C1549537:Infiltrate [Functional Concept]

Phrase: "the mucosal epithelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014609:Epithelium [Tissue]
   789 E C0221908:Epithelial [Qualitative Concept]

Phrase: "and"

Phrase: "submucosa."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225344:Submucosa [Tissue]
   928 E C1515025:Submucosal [Functional Concept]
Processing 00000000.tx.21: T cells in biopsies from the airways of subjects with asthma bear activation markers, whereas the eosinophils and mast cells show evidence of degranulation, suggesting concerted activation of these cell types. 

Phrase: "T cells in biopsies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "from the airways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178987:airways [Medical Device]
  1000   C0458827:Airways [Body Part, Organ, or Organ Component]

Phrase: "of subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with asthma bear activation markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0005516:Marker [Clinical Attribute]

Phrase: "whereas"

Phrase: "the eosinophils"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014467:Eosinophils [Cell]
  1000   C0200638:Eosinophils [Laboratory Procedure]
   916 E C0333930:Eosinophilic [Functional Concept]
   893 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   893 E C1306759:Eosinophilia [Disease or Syndrome]
   893 E C1636667:Eosinophilia [Disease or Syndrome]
   893 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "evidence of degranulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "concerted activation of these cell types."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1326120:cell activation [Cell Function]
   753   C1879547:Activation [Activity]
Processing 00000000.tx.22: The epithelium may show goblet cell metaplasia or exfoliation. 

Phrase: "The epithelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014609:Epithelium [Tissue]
   928 E C0221908:Epithelial [Qualitative Concept]

Phrase: "may"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "goblet cell metaplasia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0025568:Metaplasia [Cell or Molecular Dysfunction]
   755 E C0334023:Metaplastic [Functional Concept]
   734   C0506994:Goblet cell [Cell]

Phrase: "or"

Phrase: "exfoliation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237849:Exfoliation [Finding]
Processing 00000000.tx.23: The infiltration of the airway smooth muscle with mast cells is a feature that distinguishes asthma from eosinophilic bronchitis (3), a syndrome in which mucosal inflammation is not accompanied by AHR or airflow obstruction. 

Phrase: "The infiltration of the airway smooth muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332448:Infiltration [Pathologic Function]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]

Phrase: "with mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "that"

Phrase: "distinguishes"

Phrase: "asthma from eosinophilic bronchitis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0034068:Eosinophilic asthma [Disease or Syndrome]
   819   C0340076:Eosinophilic asthma [Disease or Syndrome]
   819   C1319018:asthma bronchitis [Disease or Syndrome]
   783 E C0004096:bronchitic asthma [Disease or Syndrome]
           Asthma
   770   C2984299:Asthma [Functional Concept]

Phrase: "(2) infiltrate the mucosal epithelium and submucosa. T cells in biopsies from the airways of subjects with asthma bear activation markers, whereas the eosinophils and mast cells show evidence of degranulation, suggesting concerted activation of these cell types. The epithelium may show goblet cell metaplasia or exfoliation. The infiltration of the airway smooth muscle with mast cells is a feature that distinguishes asthma from eosinophilic bronchitis (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a syndrome in which mucosal inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0039082:Syndrome [Disease or Syndrome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178987:Airway, NOS [Medical Device]
   770   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "airflow obstruction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028778:Obstruction [Pathologic Function]
   861   C1882136:OBSTRUCTION [Phenomenon or Process]
Processing 00000000.tx.24: Airway "remodeling" associated with chronic asthmatic inflammation is characterized by hyperplasia of smooth muscle and mucous glands and accumulation of myofibroblasts and extracellular matrix in the subepithelial region. 

Phrase: "Airway ""remodeling"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2717792:Airway Remodeling [Finding]

Phrase: "associated with chronic asthmatic inflammation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0021376:Chronic inflammation [Pathologic Function]
   760   C0004096:Asthmatic [Disease or Syndrome]
   760   C0021368:Inflammation [Pathologic Function]
   760   C0205191:chronic [Temporal Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "characterized by hyperplasia of smooth muscle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C2265815:smooth muscle hyperplasia [Physiologic Function]
   790   C1267092:Muscle, Smooth [Tissue]
   783   C2265913:muscle hyperplasia [Physiologic Function]
   753   C0020507:Hyperplasia [Pathologic Function]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "mucous glands"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0225354:Mucous gland, NOS [Body Part, Organ, or Organ Component]
   966   C1519351:Mucous Gland [Tissue]
   861   C0026727:mucous [Body Substance]
   861   C0439708:Mucous [Qualitative Concept]
   861   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "accumulation of myofibroblasts"

Phrase: "and"

Phrase: "extracellular matrix in the subepithelial region."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0015350:Extracellular Matrix [Tissue]
   783   C0521119:extracellular region [Cell Component]
           Extracellular
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
Processing 00000000.tx.25: There is considerable evidence that AHR to spasmogens such as methacholine is an intrinsic, possibly inherited trait that is regulated separately from the inflammatory response, and precedes the development of clinical asthma in most individuals (4). 

Phrase: "There"

Phrase: "is"

Phrase: "considerable evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that AHR to spasmogens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178987:Airway, NOS [Medical Device]
   760   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "such as methacholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600370:Methacholine [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "an intrinsic, possibly inherited trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0599883:Trait [Organism Attribute]

Phrase: "that"

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "separately from the inflammatory response,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1155266:Inflammatory Response [Pathologic Function]
   760   C0333348:Inflammatory [Functional Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "precedes"

Phrase: "the development of clinical asthma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "in most individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "(3), a syndrome in which mucosal inflammation is not accompanied by AHR or airflow obstruction. Airway ""remodeling"" associated with chronic asthmatic inflammation is characterized by hyperplasia of smooth muscle and mucous glands and accumulation of myofibroblasts and extracellular matrix in the subepithelial region. There is considerable evidence that AHR to spasmogens such as methacholine is an intrinsic, possibly inherited trait that is regulated separately from the inflammatory response, and precedes the development of clinical asthma in most individuals (4"

Phrase: "), a syndrome in which mucosal inflammation is not accompanied by AHR or airflow obstruction. Airway ""remodeling"" associated with chronic asthmatic inflammation is characterized by hyperplasia of smooth muscle and mucous glands and accumulation of myofibroblasts and extracellular matrix in the subepithelial region. There is considerable evidence that AHR to spasmogens such as methacholine is an intrinsic, possibly inherited trait that is regulated separately from the inflammatory response, and precedes the development of clinical asthma in most individuals (4)."
Processing 00000000.tx.26: An additional transient steroid-sensitive increment in AHR occurs following inhalation of allergen in atopic humans, indicating that allergic inflammation superimposes an inducible component of AHR onto an already hyperresponsive background (5). 

Phrase: "An additional transient steroid-sensitive increment in AHR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705117:Increment [Quantitative Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "inhalation of allergen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004048:Inhalation [Organism Function]
   790   C0205535:Inhalation [Functional Concept]
   790   C1705211:Inhalation [Quantitative Concept]

Phrase: "in atopic humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "indicating"

Phrase: "that allergic inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021375:Inflammation, allergic [Pathologic Function]
   861   C0021368:Inflammation [Pathologic Function]

Phrase: "superimposes"

Phrase: "an inducible component of AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "onto an already hyperresponsive background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706907:Background [Conceptual Entity]

Phrase: "(4). An additional transient steroid-sensitive increment in AHR occurs following inhalation of allergen in atopic humans, indicating that allergic inflammation superimposes an inducible component of AHR onto an already hyperresponsive background (5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "). An additional transient steroid-sensitive increment in AHR occurs following inhalation of allergen in atopic humans, indicating that allergic inflammation superimposes an inducible component of AHR onto an already hyperresponsive background (5)."
Processing 00000000.tx.27: Lessons from mouse models: nuggets Typical mouse models of allergen-mediated pulmonary inflammation involve intraperitoneal immunization with chicken egg ovalbumin (OVA) precipitated with aluminum hydroxide (alum), followed by repetitive challenge with OVA intratracheally, intranasally, or by aerosol. 

Phrase: "Lessons from mouse models"

Phrase: ":"

Phrase: "nuggets Typical mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "models of allergen-mediated pulmonary inflammation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0032285:Pulmonary Inflammation [Disease or Syndrome]
   753   C0002092:Allergen [Immunologic Factor]
   753   C0021368:Inflammation [Pathologic Function]
   753   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C2707265:Pulmonary [Clinical Attribute]
   753   C2709248:Pulmonary [Qualitative Concept]
   753   C3161035:Model [Intellectual Product]
   753   C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: "involve"

Phrase: "intraperitoneal immunization with chicken egg ovalbumin (OVA)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C3244291:immunization [Functional Concept]

Phrase: "precipitated with aluminum hydroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0002371:Aluminium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0220853:hydroxide [Element, Ion, or Isotope]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(5). Lessons from mouse models: nuggets Typical mouse models of allergen-mediated pulmonary inflammation involve intraperitoneal immunization with chicken egg ovalbumin (OVA) precipitated with aluminum hydroxide (alum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]

Phrase: ")"

Phrase: ","

Phrase: "followed by repetitive challenge"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0798503:Challenge [Clinical Attribute]
   770   C0805586:Challenge [Health Care Activity]
   770   C3274764:Challenge [Conceptual Entity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with OVA intratracheally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "intranasally,"

Phrase: "or by aerosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001712:Aerosol [Manufactured Object]
   790   C1112870:Aerosol [Biomedical or Dental Material]
Processing 00000000.tx.28: These conditions produce a robust eosinophilic inflammatory response that is typically distributed around bronchi and vascular structures, and AHR. 

Phrase: "These conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "produce"

Phrase: "a robust eosinophilic inflammatory response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1155266:Inflammatory Response [Pathologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "is"

Phrase: "typically"

Phrase: "distributed around bronchi"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0006255:Bronchi [Body Part, Organ, or Organ Component]
   790   C1704711:Distributed [Functional Concept]
   756 E C1235659:Bronchus [Eukaryote]
   756 E C1278907:Bronchus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vascular structures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0005847:Vascular structure [Body Part, Organ, or Organ Component]
   861   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "AHR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.29: These features are independent of IgE, B cells, or mast cells, but depend on CD4+ T lymphocytes (6). 

Phrase: "These features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "are independent of IgE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332291:Independent of [Functional Concept]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]
   770   C1551058:Are [Quantitative Concept]

Phrase: "B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "mast cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "depend on CD4+ T lymphocytes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   845   C0039215:CD4+ T Lymphocyte [Cell]
           cd4 lymphocytes
   806   C0039194:T-Lymphocytes [Cell]
   797   C3641616:CD4/Lymphocytes [Laboratory Procedure]
   760   C0024264:Lymphocytes [Cell]
   760   C0725813:depend [Medical Device]
   760   C3541261:CD4 [Laboratory Procedure]

Phrase: "(alum), followed by repetitive challenge with OVA intratracheally, intranasally, or by aerosol. These conditions produce a robust eosinophilic inflammatory response that is typically distributed around bronchi and vascular structures, and AHR. These features are independent of IgE, B cells, or mast cells, but depend on CD4+ T lymphocytes (6"

Phrase: "), followed by repetitive challenge with OVA intratracheally, intranasally, or by aerosol. These conditions produce a robust eosinophilic inflammatory response that is typically distributed around bronchi and vascular structures, and AHR. These features are independent of IgE, B cells, or mast cells, but depend on CD4+ T lymphocytes (6)."
Processing 00000000.tx.30: Effector T lymphocytes are necessary and sufficient to provide the requisite Th2 cytokines that induce both histologic changes and induced AHR. 

Phrase: "Effector T lymphocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C3641722:Effector T-Lymphocyte [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]

Phrase: "are"

Phrase: "necessary"

Phrase: "and"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the requisite Th2 cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "both histologic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "induced AHR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.31: The use of knock-out mice and/or blockade with specific antibodies in wild-type mice revealed that IL-4 signaling through the IL-4 receptor subunit (IL-4R), and subsequent STAT6-dependent transcriptional events are required for both the development of polarized OVA-specific Th2 cell populations and an IgE response from B cells (7, 8). 

Phrase: "The use of knock-out mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "and/or"

Phrase: "blockade with specific antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332206:Blockade [Functional Concept]
   770   C3540676:Blockade [Pharmacologic Substance]

Phrase: "in wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that IL-4 signaling through the IL-4 receptor subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1514762:Receptor Signaling [Molecular Function]
   739   C0037083:Signaling [Cell Function]
   739   C3537152:signaling [Biologic Function]

Phrase: "(6). Effector T lymphocytes are necessary and sufficient to provide the requisite Th2 cytokines that induce both histologic changes and induced AHR. The use of knock-out mice and/or blockade with specific antibodies in wild-type mice revealed that IL-4 signaling through the IL-4 receptor subunit (IL-4R"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subsequent STAT6-dependent transcriptional events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441471:Events [Event]
   804   C3541888:Events [Classification]

Phrase: "are"

Phrase: "required for both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "the development of polarized OVA-specific Th2 cell populations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   798   C1155044:T-helper 2 cell development [Cell Function]
   782   C3159117:T-helper cell development [Cell Function]
   751   C0815089:cell development [Cell Function]
   736   C0243107:development [Physiologic Function]
   736   C0678723:Development [Organism Function]
   736   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "an IgE response from B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(IL-4R), and subsequent STAT6-dependent transcriptional events are required for both the development of polarized OVA-specific Th2 cell populations and an IgE response from B cells (7,"

Phrase: "8"

Phrase: "), and subsequent STAT6-dependent transcriptional events are required for both the development of polarized OVA-specific Th2 cell populations and an IgE response from B cells (7, 8)."
Processing 00000000.tx.32: IgE, but not Th2 cell polarization, can also be induced by STAT6 signaling initiated by IL-13 (9), which binds to the IL-4R/IL-13R1 heterodimer expressed by B cells and stromal cells, but not by T cells. 

Phrase: "IgE,"

Phrase: "but"

Phrase: "not Th2 cell polarization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C1156002:cell polarization [Cell Function]
   795   C0946292:Polarization [Clinical Attribute]
   701   C0018894:T helper cell [Cell]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "induced by STAT6 signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037083:Signaling [Cell Function]
   770   C0205263:Induced [Functional Concept]
   770   C0297890:STAT6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1335877:STAT6 [Gene or Genome]
   770   C3537152:signaling [Biologic Function]

Phrase: "initiated by IL-13"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "(7, 8). IgE, but not Th2 cell polarization, can also be induced by STAT6 signaling initiated by IL-13 (9"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "binds to the IL-4R/IL-13R1 heterodimer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "expressed by B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0004561:B-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "stromal cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0162597:Stromal Cells [Cell]
   947 E C0596291:stroma cell [Cell Component]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "not by T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.33: Although dispensable for IgE generation, IL-13 is the major effector of airway mucosal pathology, targeting the epithelium for goblet cell metaplasia, epithelial cellderived chemokine production, and AHR (10). 

Phrase: "Although"

Phrase: "dispensable for IgE generation,"

Phrase: "IL-13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "the major effector of airway mucosal pathology,"

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the epithelium for goblet cell metaplasia,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1513172:Metaplastic Epithelial Cell [Cell]
   753   C0014609:Epithelium [Tissue]
   748   C0014597:Epithelial cell [Cell]
   748   C1317977:Epithelial metaplasia [Cell or Molecular Dysfunction]

Phrase: "epithelial cellderived chemokine production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1819426:chemokine production [Organism Function]
   812   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "(9), which binds to the IL-4R/IL-13R1 heterodimer expressed by B cells and stromal cells, but not by T cells. Although dispensable for IgE generation, IL-13 is the major effector of airway mucosal pathology, targeting the epithelium for goblet cell metaplasia, epithelial cellderived chemokine production, and AHR (10"

Phrase: "), which binds to the IL-4R/IL-13R1 heterodimer expressed by B cells and stromal cells, but not by T cells. Although dispensable for IgE generation, IL-13 is the major effector of airway mucosal pathology, targeting the epithelium for goblet cell metaplasia, epithelial cellderived chemokine production, and AHR (10)."
Processing 00000000.tx.34: The perivascular and peribronchial eosinophilia that is consistently observed in these models reflects the concerted actions of IL-5 and the chemokine eotaxin-1 (CCL13), the latter being a major product of IL-13stimulated bronchial epithelial cells (11). 

Phrase: "The perivascular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442165:Perivascular [Spatial Concept]

Phrase: "and"

Phrase: "peribronchial eosinophilia"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0014457:Eosinophilia [Disease or Syndrome]
   861   C1306759:Eosinophilia [Disease or Syndrome]
   861   C1636667:Eosinophilia [Disease or Syndrome]
   861   C2240374:Eosinophilia [Finding]
   789 E C0333930:Eosinophilic [Functional Concept]
   761 E C0014467:Eosinophils [Cell]
   761 E C0200638:Eosinophils [Laboratory Procedure]

Phrase: "that"

Phrase: "is"

Phrase: "consistently"

Phrase: "observed in these models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441672:Observed [Functional Concept]
   770   C3161035:Models [Intellectual Product]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the concerted actions of IL-5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441472:actions [Functional Concept]
   719 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "the chemokine eotaxin-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0250604:Eotaxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Eotaxin
   901   C1332676:eotaxin-1 [Gene or Genome]
           EOTAXIN
   827   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527022:Eotaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10). The perivascular and peribronchial eosinophilia that is consistently observed in these models reflects the concerted actions of IL-5 and the chemokine eotaxin-1 (CCL13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390071:CCL13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332677:CCL13 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the latter"

Phrase: "being"

Phrase: "a major product of IL-13stimulated bronchial epithelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "(CCL13), the latter being a major product of IL-13stimulated bronchial epithelial cells (11"

Phrase: "), the latter being a major product of IL-13stimulated bronchial epithelial cells (11)."
Processing 00000000.tx.35: Overexpression of IL-13 in the pulmonary epithelium also induces signature features of airway remodeling through activation of TGF-1matrix metalloprotease signaling (12). 

Phrase: "Overexpression of IL-13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C1512843:Interleukin-13 Overexpression [Laboratory or Test Result]
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in the pulmonary epithelium also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014609:Epithelium [Tissue]
   755 E C0221908:Epithelial [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "signature features of airway remodeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "through activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of TGF-1matrix metalloprotease signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "(11). Overexpression of IL-13 in the pulmonary epithelium also induces signature features of airway remodeling through activation of TGF-1matrix metalloprotease signaling (12"

Phrase: "). Overexpression of IL-13 in the pulmonary epithelium also induces signature features of airway remodeling through activation of TGF-1matrix metalloprotease signaling (12)."
Processing 00000000.tx.36: Thus, IL-4dependent polarization of T cells provides the effector cytokines responsible for the core pathobiology of mouse models. 

Phrase: "Thus,"

Phrase: "IL-4dependent polarization of T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1326152:T-cell polarization [Cell Function]
   767   C1156002:cell polarization [Cell Function]
   753   C0946292:Polarization [Clinical Attribute]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the effector cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "responsible for the core pathobiology of mouse models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]
Processing 00000000.tx.37: Variables contributing to disparate experimental outcomes Although allergen-induced models of pulmonary inflammation consistently elicit the features noted above in mice, discrepancies exist between models. 

Phrase: "Variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:variables [Qualitative Concept]

Phrase: "contributing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contributing [Activity]

Phrase: "to disparate experimental outcomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1274040:Outcome [Functional Concept]

Phrase: "Although"

Phrase: "allergen-induced models of pulmonary inflammation consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Models [Intellectual Product]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "the features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "above in mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1282910:Above [Spatial Concept]
   790   C1552828:above [Idea or Concept]

Phrase: "discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:discrepancies [Finding]

Phrase: "exist between models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2987476:Exist [Conceptual Entity]
   790   C3161035:Models [Intellectual Product]
Processing 00000000.tx.38: These discrepancies reflect several critical experimental variables noted below. 

Phrase: "These discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:discrepancies [Finding]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "several critical experimental variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439828:variables [Qualitative Concept]

Phrase: "noted below."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1316572:Note [Clinical Attribute]
   799   C1317574:Note [Intellectual Product]
   799   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.39: Strain. 

Phrase: "Strain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
Processing 00000000.tx.40: The most commonly used mouse strains in models of experimentally induced airway disease, BALB/c and C57BL/6, differ sharply in their propensity to Th2 versus Th1 cytokine production in response to certain infectious agents (13). 

Phrase: "The most commonly used mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "strains in models of experimentally induced airway disease,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0699949:airway disease [Disease or Syndrome]
   767   C0683033:disease models [Intellectual Product]
   767   C0684309:disease models [Experimental Model of Disease]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0080194:Strain [Injury or Poisoning]
   744   C0178987:Airway, NOS [Medical Device]
   744   C0205263:Induced [Functional Concept]
   744   C0456178:strain [Intellectual Product]
   744   C0458827:Airway [Body Part, Organ, or Organ Component]
   744   C1518614:Strain [Organism]
   744   C2987481:Strain [Mental Process]
   744   C3161035:Models [Intellectual Product]

Phrase: "BALB/c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "and"

Phrase: "C57BL/6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: "differ"

Phrase: "sharply in their propensity"

Phrase: "to Th2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441730:Type 2 [Classification]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "versus"

Phrase: "Th1 cytokine production in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1327413:cytokine production [Organism Function]
   760   C0033268:production [Occupational Activity]

Phrase: "to certain infectious agents"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0314732:Infectious Agents [Organism]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
   755   C0009450:Infection, NOS [Disease or Syndrome]
   734 E C0030657:infectivity [Qualitative Concept]
   727 E C0439663:Infected [Functional Concept]

Phrase: "(12). Thus, IL-4dependent polarization of T cells provides the effector cytokines responsible for the core pathobiology of mouse models. Variables contributing to disparate experimental outcomes Although allergen-induced models of pulmonary inflammation consistently elicit the features noted above in mice, discrepancies exist between models. These discrepancies reflect several critical experimental variables noted below. Strain. The most commonly used mouse strains in models of experimentally induced airway disease, BALB/c and C57BL/6, differ sharply in their propensity to Th2 versus Th1 cytokine production in response to certain infectious agents (13"

Phrase: "). Thus, IL-4dependent polarization of T cells provides the effector cytokines responsible for the core pathobiology of mouse models. Variables contributing to disparate experimental outcomes Although allergen-induced models of pulmonary inflammation consistently elicit the features noted above in mice, discrepancies exist between models. These discrepancies reflect several critical experimental variables noted below. Strain. The most commonly used mouse strains in models of experimentally induced airway disease, BALB/c and C57BL/6, differ sharply in their propensity to Th2 versus Th1 cytokine production in response to certain infectious agents (13)."
Processing 00000000.tx.41: In an analogous fashion, BALB/c mice develop a vigorous Th2 response following sensitization and challenge with OVA, characteristically involving more profound pulmonary eosinophilia, higher levels of allergen-specific IgE, and greater levels of induced AHR compared with C57BL/6 mice (8). 

Phrase: "In an analogous fashion,"

Phrase: "BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "develop"

Phrase: "a vigorous Th2 response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0871261:Response [Organism Attribute]
   799   C1704632:Response [Finding]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1325847:Sensitisation [Mental Process]

Phrase: "and"

Phrase: "challenge with OVA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0798503:Challenge [Clinical Attribute]
   790   C0805586:Challenge [Health Care Activity]
   790   C3274764:Challenge [Conceptual Entity]

Phrase: "characteristically"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "more profound pulmonary eosinophilia,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0034068:Pulmonary Eosinophilia [Disease or Syndrome]
   861   C0340076:Pulmonary eosinophilia [Disease or Syndrome]
   812   C0014457:Eosinophilia [Disease or Syndrome]
   812   C1306759:Eosinophilia [Disease or Syndrome]
   812   C1636667:Eosinophilia [Disease or Syndrome]
   812   C2240374:Eosinophilia [Finding]
   741 E C0333930:Eosinophilic [Functional Concept]
   712 E C0014467:Eosinophils [Cell]
   712 E C0200638:Eosinophils [Laboratory Procedure]

Phrase: "higher levels of allergen-specific IgE,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "greater levels of induced AHR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with C57BL/6 mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   797   C0025921:Mice, C57BL [Mammal]
           C57BL
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1707455:Compared [Activity]

Phrase: "(13). In an analogous fashion, BALB/c mice develop a vigorous Th2 response following sensitization and challenge with OVA, characteristically involving more profound pulmonary eosinophilia, higher levels of allergen-specific IgE, and greater levels of induced AHR compared with C57BL/6 mice (8"

Phrase: "). In an analogous fashion, BALB/c mice develop a vigorous Th2 response following sensitization and challenge with OVA, characteristically involving more profound pulmonary eosinophilia, higher levels of allergen-specific IgE, and greater levels of induced AHR compared with C57BL/6 mice (8)."
Processing 00000000.tx.42: BALB/c mice differ from C57BL/6 mice at genetic loci on chromosome 11 that control the robustness of IL-4 responses of T cells, a region syntenic with human chromosome 5q23-35 (14). 

Phrase: "BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "differ from C57BL/6 mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   851   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   797   C0025921:Mice, C57BL [Mammal]
           C57BL
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "at genetic loci"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
  1000   C0678933:Genetic Loci [Gene or Genome]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1708726:Locus [Gene or Genome]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "on chromosome 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008653:Chromosome 11 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the robustness of IL-4 responses of T cells,"

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "syntenic with human chromosome 5q23-35"

Phrase: "(8). BALB/c mice differ from C57BL/6 mice at genetic loci on chromosome 11 that control the robustness of IL-4 responses of T cells, a region syntenic with human chromosome 5q23-35 (14"

Phrase: "). BALB/c mice differ from C57BL/6 mice at genetic loci on chromosome 11 that control the robustness of IL-4 responses of T cells, a region syntenic with human chromosome 5q23-35 (14)."
Processing 00000000.tx.43: This region contains the Th2 cytokine gene cluster, as well as a possible regulator of Th2 responses, T cell Ig domain, mucin domain-1, the mouse homologue of the hepatitis A receptor. 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the Th2 cytokine gene cluster,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0017258:Gene cluster [Gene or Genome]
   795   C1555715:Cluster [Idea or Concept]
   795   C1704332:Cluster [Quantitative Concept]

Phrase: "as well as"

Phrase: "a possible regulator of Th2 responses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0182953:REGULATOR [Medical Device]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]

Phrase: "T cell Ig domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "mucin domain-1,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0006611:Mucin-1 [Amino Acid, Peptide, or Protein,Carbohydrate,Immunologic Factor]
   913   C0057628:Mucin-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Mucin
   827   C0026682:Mucin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
   755 E C1513712:Mucinous [Qualitative Concept]

Phrase: "the mouse homologue of the hepatitis A receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.44: Thus, the choice of strain may profoundly alter experimental outcomes in these lymphocytedependent models. 

Phrase: "Thus,"

Phrase: "the choice of strain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0008300:choice [Individual Behavior]
   770   C1707391:Choice [Activity]

Phrase: "may"

Phrase: "profoundly"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "experimental outcomes in these lymphocytedependent models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.45: The fact that most available knock-out strains of mice are created on a C57BL/6 genetic background has important implications for interpretations of allergic disease models where these mice are used. 

Phrase: "The fact"

Phrase: "that"

Phrase: "most available knock-out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0560617:knock out [Injury or Poisoning]
   901   C1522225:Knock-out [Experimental Model of Disease]
   827   C0439787:Out [Spatial Concept]
   827   C0849355:Out [Qualitative Concept]

Phrase: "strains of mice"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   841   C1513684:Mouse Strains [Mammal]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0080194:Strain [Injury or Poisoning]
   790   C0456178:strain [Intellectual Product]
   790   C1518614:Strain [Organism]
   790   C2987481:Strain [Mental Process]
   734 E C0180860:Filter [Manufactured Object]
   734 E C0581406:Filter [Medical Device]
   734 E C1522664:Filter [Intellectual Product]
   734 E C1704449:Filter [Conceptual Entity]
   734 E C1704684:Filter [Medical Device]
   734 E C1875155:FILTER [Medical Device]
   706 E C0442694:Straining [Physiologic Function]

Phrase: "are"

Phrase: "created on a C57BL/6 genetic background"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1521751:C57BL/6 [Mammal]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0025921:C57BL [Mammal]
   748   C0314603:Genetic [Functional Concept]
   748   C1706214:Created [Activity]
   748   C1706907:Background [Conceptual Entity]
   714 E C3244320:create [Functional Concept]

Phrase: "has"

Phrase: "important implications for interpretations of allergic disease models where"

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.46: Furthermore, the backcrossing of C57BL/6 mice to the BALB/c background introduces the potential for confounding influences of retained C57BL/6 genes on chromosome 11 that may complicate comparisons with wild-type BALB/c mice, or even littermate controls. 

Phrase: "Furthermore,"

Phrase: "the backcrossing of C57BL/6 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524616:Backcrossing [Organism Function]

Phrase: "to the BALB/c background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706907:Background [Conceptual Entity]
   734   C0025919:BALB/C [Mammal]

Phrase: "introduces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:Introduces [Functional Concept]

Phrase: "the potential for confounding influences of retained C57BL/6 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3245505:Potential [Qualitative Concept]

Phrase: "on chromosome 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008653:Chromosome 11 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "that"

Phrase: "may"

Phrase: "complicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:complicate [Functional Concept]

Phrase: "comparisons with wild-type BALB/c mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707455:Comparison [Activity]

Phrase: "or"

Phrase: "even littermate controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.47: As is the case with primary immune responses, innate tissue responses also differ amongst strains. 

Phrase: "As is"

Phrase: "the case with primary immune responses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "innate tissue responses also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "differ amongst strains."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0080194:Strains [Injury or Poisoning]
   790   C0456178:strains [Intellectual Product]
   756 E C1518614:Strain [Organism]
   756 E C2987481:Strain [Mental Process]
Processing 00000000.tx.48: Most mice are nonreactive or poorly reactive to pharmacologic bronchoconstrictors (15), and lack airway smooth muscle below the first few bronchial generations. 

Phrase: "Most mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "nonreactive"

Phrase: "or"

Phrase: "poorly reactive to pharmacologic bronchoconstrictors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205332:Reactive [Qualitative Concept]

Phrase: "(14). This region contains the Th2 cytokine gene cluster, as well as a possible regulator of Th2 responses, T cell Ig domain, mucin domain-1, the mouse homologue of the hepatitis A receptor. Thus, the choice of strain may profoundly alter experimental outcomes in these lymphocytedependent models. The fact that most available knock-out strains of mice are created on a C57BL/6 genetic background has important implications for interpretations of allergic disease models where these mice are used. Furthermore, the backcrossing of C57BL/6 mice to the BALB/c background introduces the potential for confounding influences of retained C57BL/6 genes on chromosome 11 that may complicate comparisons with wild-type BALB/c mice, or even littermate controls. As is the case with primary immune responses, innate tissue responses also differ amongst strains. Most mice are nonreactive or poorly reactive to pharmacologic bronchoconstrictors (15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lack airway smooth muscle below the first few bronchial generations."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1267092:Muscle, Smooth [Tissue]
   757   C0225605:Bronchial muscle [Body Part, Organ, or Organ Component]
   739   C0026845:Muscle [Tissue]
   739   C0178987:Airway, NOS [Medical Device]
   739   C0205357:Smooth [Qualitative Concept]
   739   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.49: However, A/J mice exhibit marked methacholine-induced bronchconstriction that is independent of allergen sensitization and challenge (referred to as naive AHR) (16). 

Phrase: "However,"

Phrase: "A/J mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1510707:A/J Mouse [Mammal]
           A/J
   896   C1522424:A Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "marked methacholine-induced bronchconstriction"

Phrase: "that"

Phrase: "is independent of allergen sensitization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332291:Independent of [Functional Concept]
   760   C0002092:Allergen [Immunologic Factor]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1325847:Sensitisation [Mental Process]
   760   C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "naive AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "(referred to as naive AHR) (16"

Phrase: ") (16)."
Processing 00000000.tx.50: The naive AHR of the A/J strain is not associated with a definable abnormality in airway histology, and is not abrogated by crossing these mice with either Rag2-deficient mice (which lack mature B and T cells) or mice lacking IL-4R (17). 

Phrase: "The naive AHR of the A/J strain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0178987:Airway, NOS [Medical Device]
   742   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with a definable abnormality"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1704258:Abnormality [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in airway histology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019638:Histology [Biomedical Occupation or Discipline]
   861   C0205462:histology [Functional Concept]
   861   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "abrogated by crossing"

Phrase: "these mice with either Rag2-deficient mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C0025914:mouse, mice [Mammal]

Phrase: "("

Phrase: "which"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "mature B"

Phrase: "and"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "IL-4R"

Phrase: "(which lack mature B and T cells) or mice lacking IL-4R (17"

Phrase: ") or mice lacking IL-4R (17)."
Processing 00000000.tx.51: The genotyping of phenotypically selected A/J mice that were bred over 8 generations onto the C57BL/6 background (which is hyporesponsive to methacholine) revealed that naive AHR is conferred by a major locus on A/J chromosome 2, and an interacting locus on chromosome 6 (18). 

Phrase: "The genotyping of phenotypically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1285573:Genotyping [Laboratory Procedure]

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "A/J mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1510707:A/J Mouse [Mammal]
           A/J
   896   C1522424:A Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "bred over 8 generations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0079411:Generations [Temporal Concept]
   737   C0006159:breed [Organism Function]
   737   C1704650:Breed [Classification]
   737 E C3146294:Generation [Activity]

Phrase: "onto the C57BL/6 background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706907:Background [Conceptual Entity]
   734   C1521751:C57BL/6 [Mammal]

Phrase: "("

Phrase: "which"

Phrase: "is"

Phrase: "hyporesponsive to methacholine"

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that naive AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "conferred by a major locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205164:Major [Qualitative Concept]
   760   C1708726:Locus [Gene or Genome]

Phrase: "on A/J chromosome 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1825406:A-2 [Gene or Genome]
   861   C0008662:Chromosome 2 [Cell Component]
   861   C1510707:A/J [Mammal]
   812   C0008633:Chromosome [Cell Component]

Phrase: "and"

Phrase: "an interacting locus on chromosome 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "(which is hyporesponsive to methacholine) revealed that naive AHR is conferred by a major locus on A/J chromosome 2, and an interacting locus on chromosome 6 (18"

Phrase: ") revealed that naive AHR is conferred by a major locus on A/J chromosome 2, and an interacting locus on chromosome 6 (18)."
Processing 00000000.tx.52: It is noteworthy that chromosome 2 contains the mouse orthologue of a dysintergrin and metalloprotease 33 (ADAM-33), which was recently reported to be a gene with linkage to AHR in some humans studies. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that chromosome 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008662:Chromosome 2 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the mouse orthologue of a dysintergrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1335144:Ortholog [Gene or Genome]

Phrase: "and"

Phrase: "metalloprotease 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(18). It is noteworthy that chromosome 2 contains the mouse orthologue of a dysintergrin and metalloprotease 33 (ADAM-33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423517:ADAM33 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a gene with linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0079429:A Gene [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]

Phrase: "to AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "in some humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "studies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.53: A/J mice also develop exuberant smooth muscle hyperplasia, eosinophilia, IL-13 production, and peribronchial fibrosis in response to repetitive intranasal administration of OVA in the absence of systemic sensitization, whereas BALB/c, C57BL/6, and C3H/Hej mice fail to respond to this protocol (19). 

Phrase: "A/J mice also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   912   C1510707:A/J Mouse [Mammal]
           A/J
   858   C1522424:A Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "develop"

Phrase: "exuberant smooth muscle hyperplasia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C2265815:smooth muscle hyperplasia [Physiologic Function]
   861   C2265913:muscle hyperplasia [Physiologic Function]
   812   C0020507:Hyperplasia [Pathologic Function]

Phrase: "eosinophilia,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0014457:Eosinophilia [Disease or Syndrome]
  1000   C1306759:Eosinophilia [Disease or Syndrome]
  1000   C1636667:Eosinophilia [Disease or Syndrome]
  1000   C2240374:Eosinophilia [Finding]
   928 E C0333930:Eosinophilic [Functional Concept]
   900 E C0014467:Eosinophils [Cell]
   900 E C0200638:Eosinophils [Laboratory Procedure]

Phrase: "IL-13 production,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1819440:interleukin-13 production [Organism Function]
   913   C3159141:interleukin production [Organism Function]
   827   C0033268:production [Occupational Activity]
   734   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "peribronchial fibrosis in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016059:Fibrosis [Pathologic Function]

Phrase: "to repetitive intranasal administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0001560:Administration, Intranasal [Therapeutic or Preventive Procedure]
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of systemic sensitization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1325847:Sensitisation [Mental Process]

Phrase: "whereas"

Phrase: "BALB/c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "C57BL/6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: "and"

Phrase: "C3H/Hej mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1511362:C3H/HeJ Mouse [Mammal]
           C3H/HeJ
   913   C0025920:Mice, C3H [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "respond to this protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442711:Protocol [Intellectual Product]
   770   C1507394:Protocol [Intellectual Product]
   770   C1522729:Protocol [Intellectual Product]
   770   C2348563:Protocol [Intellectual Product]

Phrase: "(ADAM-33), which was recently reported to be a gene with linkage to AHR in some humans studies. A/J mice also develop exuberant smooth muscle hyperplasia, eosinophilia, IL-13 production, and peribronchial fibrosis in response to repetitive intranasal administration of OVA in the absence of systemic sensitization, whereas BALB/c, C57BL/6, and C3H/Hej mice fail to respond to this protocol (19"

Phrase: "), which was recently reported to be a gene with linkage to AHR in some humans studies. A/J mice also develop exuberant smooth muscle hyperplasia, eosinophilia, IL-13 production, and peribronchial fibrosis in response to repetitive intranasal administration of OVA in the absence of systemic sensitization, whereas BALB/c, C57BL/6, and C3H/Hej mice fail to respond to this protocol (19)."
Processing 00000000.tx.54: Thus, existing mouse models can address the role of a given cell, mediator, or gene unequivocally on a single genetic background, but cannot address how broadly applicable a finding might be to an analogous experiment performed in a different strain. 

Phrase: "Thus,"

Phrase: "existing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2987476:Exist [Conceptual Entity]

Phrase: "mouse models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Models [Intellectual Product]

Phrase: "can"

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the role of a given cell,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "mediator,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "gene unequivocally on a single genetic background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Gene [Gene or Genome]

Phrase: "but"

Phrase: "cannot"

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "how broadly applicable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272460:applicable [Qualitative Concept]
   827   C1706839:Applicable [Qualitative Concept]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "might"

Phrase: "be to an analogous experiment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681814:Experiment [Research Activity]
   760   C1706386:Experiment [Conceptual Entity]
   760   C2987476:Be [Conceptual Entity]

Phrase: "performed in a different strain."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0080194:Strain [Injury or Poisoning]
   760   C0456178:strain [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   760   C1518614:Strain [Organism]
   760   C1705242:Different [Qualitative Concept]
   760   C2987481:Strain [Mental Process]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.55: It is nonetheless tempting to speculate that naive AHR and a propensity for the development of exuberant remodeling in the A/J strain could be genetically linked in a manner directly relevant to human asthma. 

Phrase: "It"

Phrase: "is"

Phrase: "nonetheless"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that naive AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a propensity for the development of exuberant remodeling"

Phrase: "in the A/J strain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]
   734   C1510707:A/J [Mammal]

Phrase: "could"

Phrase: "be"

Phrase: "genetically"

Phrase: "linked in a manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "directly relevant to human asthma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.56: Method of sensitization and nature of allergen. 

Phrase: "Method of sensitization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025663:Method [Intellectual Product]
   790   C0449851:Method [Functional Concept]
   790   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "nature of allergen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349590:Nature [Idea or Concept]
   790   C1262865:Nature [Functional Concept]
   718 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.57: Toll-like receptors (TLRs) serve as innate receptors for pathogen-associated molecular patterns (PAMPs) and are a basis for the adjuvant effects of microbial constituents. 

Phrase: "Toll-like receptors (TLRs)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0670896:Toll-like receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   827   C1336636:TOLL [Gene or Genome]
   827   C1705581:TOLL [Gene or Genome]

Phrase: "serve as innate receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for pathogen-associated molecular patterns"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   812   C0332281:Associated [Qualitative Concept]
   812   C0449774:Patterns [Spatial Concept]
   812   C0450254:Pathogen [Organism]
   812   C1521991:Molecular [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
   741 E C0567416:Molecule [Substance]
   712 E C0030657:pathogenicity [Qualitative Concept]
   712 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "(19). Thus, existing mouse models can address the role of a given cell, mediator, or gene unequivocally on a single genetic background, but cannot address how broadly applicable a finding might be to an analogous experiment performed in a different strain. It is nonetheless tempting to speculate that naive AHR and a propensity for the development of exuberant remodeling in the A/J strain could be genetically linked in a manner directly relevant to human asthma. Method of sensitization and nature of allergen. Toll-like receptors (TLRs) serve as innate receptors for pathogen-associated molecular patterns (PAMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421554:PAMP [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "a basis for the adjuvant effects of microbial constituents."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.58: Among other effects, PAMPs stimulate maturation of antigen presenting cells (APCs), and some can differentially potentiate subsequent Th1 or Th2 immune responses. 

Phrase: "Among other effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "PAMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421554:PAMP [Gene or Genome]

Phrase: "stimulate"

Phrase: "maturation of antigen presenting cells (APCs),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1516349:Cell Maturation [Cell Function]
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "some"

Phrase: "can"

Phrase: "differentially"

Phrase: "potentiate"

Phrase: "subsequent Th1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1423842:TH1 [Gene or Genome]
   861   C3540579:TH1 [Gene or Genome]

Phrase: "or"

Phrase: "Th2 immune responses."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   890   C3159116:type 2 immune response [Organ or Tissue Function]
   827   C0301872:immune responses [Organ or Tissue Function]
   799   C0439662:Immune [Functional Concept]
   799   C0871261:responses [Organism Attribute]
   766 E C1704632:Response [Finding]
   766 E C1706817:Response [Intellectual Product]
   766 E C2911692:Response [Mental Process]
Processing 00000000.tx.59: The common experimental practice of inducing sensitization using intraperitoneal injections of alum-precipitated OVA bypasses this microbial influence. 

Phrase: "The common experimental practice of inducing sensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237607:practice [Mental Process]
   748   C3245512:practice [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "intraperitoneal injections of alum-precipitated OVA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0021493:Injections, Intraperitoneal [Therapeutic or Preventive Procedure]
   753   C0021485:injections [Therapeutic or Preventive Procedure]
   753   C0442120:Intraperitoneal [Spatial Concept]
   753   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   753   C1828121:Injections [Functional Concept]
   719 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "bypasses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0741847:Bypass [Therapeutic or Preventive Procedure]

Phrase: "this microbial influence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0021399:influential [Idea or Concept]
Processing 00000000.tx.60: Resident APCs in the peritoneal cavity show signs of constitutive maturation, as evidenced by high levels of the costimulatory molecules CD40 and CD86, and MHC class II expression, even in mice that are deficient in TLR4, the receptor for lipopolysaccharide (LPS), or the adaptor molecule MyD88, which is used by most TLRs (20). 

Phrase: "Resident APCs in the peritoneal cavity"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   800   C0003315:Antigen-Presenting Cells [Cell]
   750   C1179886:Cell cavity [Body Space or Junction]
   744   C0003320:Antigen [Immunologic Factor]
   744   C0007634:Cells [Cell]
   744   C0449450:Presenting [Idea or Concept]
   744   C3282337:Cells [Cell]
   711 E C0150312:Present [Quantitative Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "signs of constitutive maturation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "as"

Phrase: "evidenced by high levels of the costimulatory molecules CD40"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   773   C0393009:Levels of Evidence [Finding]
           evidence level
   748   C2985420:Costimulatory Molecule [Amino Acid, Peptide, or Protein]
   745   C0054959:CD40 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   745   C0332120:Evidence of [Functional Concept]
           Evidence
   742   C0205250:High [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0567416:molecules [Substance]
   742   C1299351:High [Qualitative Concept]
   742   C2700149:HIGH [Intellectual Product]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "CD86,"

Phrase: "and"

Phrase: "MHC class II expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0017349:MHC Class II [Gene or Genome]

Phrase: "even in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "are"

Phrase: "deficient in TLR4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011155:Deficient [Functional Concept]
   790   C1636779:% deficient [Quantitative Concept]

Phrase: "the receptor for lipopolysaccharide (LPS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0108768:Lipopolysaccharide Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "the adaptor molecule MyD88,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1417530:MYD88 [Gene or Genome]
   827   C2983365:MYD88 [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "is"

Phrase: "used by most TLRs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0670896:Toll-like receptors [Amino Acid, Peptide, or Protein,Receptor]
   790   C1273517:Used by [Finding]
           used
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   753   C1336636:TOLL [Gene or Genome]
   753   C1705581:TOLL [Gene or Genome]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(PAMPs) and are a basis for the adjuvant effects of microbial constituents. Among other effects, PAMPs stimulate maturation of antigen presenting cells (APCs), and some can differentially potentiate subsequent Th1 or Th2 immune responses. The common experimental practice of inducing sensitization using intraperitoneal injections of alum-precipitated OVA bypasses this microbial influence. Resident APCs in the peritoneal cavity show signs of constitutive maturation, as evidenced by high levels of the costimulatory molecules CD40 and CD86, and MHC class II expression, even in mice that are deficient in TLR4, the receptor for lipopolysaccharide (LPS), or the adaptor molecule MyD88, which is used by most TLRs (20"

Phrase: ") and are a basis for the adjuvant effects of microbial constituents. Among other effects, PAMPs stimulate maturation of antigen presenting cells (APCs), and some can differentially potentiate subsequent Th1 or Th2 immune responses. The common experimental practice of inducing sensitization using intraperitoneal injections of alum-precipitated OVA bypasses this microbial influence. Resident APCs in the peritoneal cavity show signs of constitutive maturation, as evidenced by high levels of the costimulatory molecules CD40 and CD86, and MHC class II expression, even in mice that are deficient in TLR4, the receptor for lipopolysaccharide (LPS), or the adaptor molecule MyD88, which is used by most TLRs (20)."
Processing 00000000.tx.61: In contrast, resident lung APCs do not constitutively express maturation markers, accounting for the fact that sensitization to OVA administered solely by intranasal administration requires the concomitant provision of LPS. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "resident lung APCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   884   C0003315:Antigen-Presenting Cells [Cell]
   804   C0003320:Antigen [Immunologic Factor]
   804   C0007634:Cells [Cell]
   804   C0449450:Presenting [Idea or Concept]
   804   C3282337:Cells [Cell]
   771 E C0150312:Present [Quantitative Concept]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   704 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "do"

Phrase: "not constitutively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "maturation markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "accounting for the fact"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0000938:Accounting [Occupational Activity]
   737 E C1551359:account [Idea or Concept]
   737 E C2741673:Account # [Clinical Attribute]
   737 E C2981730:Account [Classification]

Phrase: "that sensitization to OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1325847:Sensitisation [Mental Process]

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "solely by intranasal administration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0001560:Administration, Intranasal [Therapeutic or Preventive Procedure]
   770   C0001554:Administration [Occupational Activity]
   770   C0442118:Intranasal [Spatial Concept]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "requires"

Phrase: "the concomitant provision of LPS."
Processing 00000000.tx.62: Moreover, the dose of LPS used is critical: the immune response to the OVA is strongly Th2-like with sensitization in the context of low-dose LPS, but Th1-like with high-dose LPS. 

Phrase: "Moreover,"

Phrase: "the dose of LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "critical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]

Phrase: ":"

Phrase: "the immune response to the OVA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0301872:Immune response [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "strongly Th2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0441730:Type 2 [Classification]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "like"

Phrase: "with sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1325847:Sensitisation [Mental Process]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of low-dose LPS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023810:Lipopolysaccharide [Lipid]
   734   C0445550:Low dose [Quantitative Concept]
   734   C1708745:Low-Dose [Research Activity]

Phrase: "but"

Phrase: "Th1-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1423842:TH1 [Gene or Genome]
   833   C3540579:TH1 [Gene or Genome]

Phrase: "with high-dose LPS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0023810:Lipopolysaccharide [Lipid]
   734   C0444956:High dose [Quantitative Concept]
Processing 00000000.tx.63: Both the Th2 and Th1 responses require TLR4 and MyD88 in this model (20). 

Phrase: "Both"

Phrase: "the Th2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441730:Type 2 [Classification]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Th1 responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "require"

Phrase: "TLR4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336636:TLR-4 [Gene or Genome]

Phrase: "and"

Phrase: "MyD88 in this model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1417530:MYD88 [Gene or Genome]
   770   C2983365:MYD88 [Amino Acid, Peptide, or Protein]

Phrase: "(20). In contrast, resident lung APCs do not constitutively express maturation markers, accounting for the fact that sensitization to OVA administered solely by intranasal administration requires the concomitant provision of LPS. Moreover, the dose of LPS used is critical: the immune response to the OVA is strongly Th2-like with sensitization in the context of low-dose LPS, but Th1-like with high-dose LPS. Both the Th2 and Th1 responses require TLR4 and MyD88 in this model (20"

Phrase: "). In contrast, resident lung APCs do not constitutively express maturation markers, accounting for the fact that sensitization to OVA administered solely by intranasal administration requires the concomitant provision of LPS. Moreover, the dose of LPS used is critical: the immune response to the OVA is strongly Th2-like with sensitization in the context of low-dose LPS, but Th1-like with high-dose LPS. Both the Th2 and Th1 responses require TLR4 and MyD88 in this model (20)."
Processing 00000000.tx.64: Thus, while intraperitoneal sensitization with alum-precipitated OVA reliably permits a robust Th2 response in the lung, it bypasses a range of signals from innate receptors that likely modify the nature of the immune and effector responses to allergens. 

Phrase: "Thus,"

Phrase: "while"

Phrase: "intraperitoneal sensitization with alum-precipitated OVA reliably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1325847:Sensitisation [Mental Process]

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "a robust Th2 response in the lung,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: "it"

Phrase: "bypasses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0741847:Bypass [Therapeutic or Preventive Procedure]

Phrase: "a range of signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "from innate receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the nature of the immune"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "and"

Phrase: "effector responses to allergens."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]
Processing 00000000.tx.65: In contrast to the weak sensitizing properties of OVA in the lung, protease-containing allergens (derived from cockroach, dust mites, and fungi) efficiently sensitize mice through intranasal application without the requirement for systemic immunization or adjuvant (21). 

Phrase: "In contrast to the weak sensitizing properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "of OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "protease-containing allergens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0002092:Allergens [Immunologic Factor]
   827   C0802014:Allergens [Clinical Attribute]
   793 E C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "derived from cockroach,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0009208:Cockroach [Eukaryote]
   790   C0600185:Cockroach [Eukaryote]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "dust mites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0998367:dust mites [Eukaryote]
  1000   C1699697:dust mites [Intellectual Product]
   861   C0026231:Mites [Eukaryote]

Phrase: "and"

Phrase: "fungi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016832:Fungi [Fungus]
  1000   C0521033:fungi [Functional Concept]

Phrase: ")"

Phrase: "efficiently"

Phrase: "sensitize"

Phrase: "mice through intranasal application"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "without the requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Requirement [Functional Concept]

Phrase: "for systemic immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C3244291:immunization [Functional Concept]

Phrase: "or"

Phrase: "adjuvant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
  1000   C0001552:Adjuvant [Chemical Viewed Functionally]
  1000   C1522673:Adjuvant [Functional Concept]

Phrase: "(derived from cockroach, dust mites, and fungi) efficiently sensitize mice through intranasal application without the requirement for systemic immunization or adjuvant (21"

Phrase: ") efficiently sensitize mice through intranasal application without the requirement for systemic immunization or adjuvant (21)."
Processing 00000000.tx.66: Such "natural allergens," which also elicit sensitization in human subjects, may function by directly activating cells of the innate immune system (APCs and mast cells) (21, 22), thus fulfilling the functions of both adjuvants and antigens. 

Phrase: "Such ""natural allergens,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002092:Allergens [Immunologic Factor]
   861   C0802014:Allergens [Clinical Attribute]
   827 E C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: """"

Phrase: "which also"

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "sensitization in human subjects,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1325847:Sensitisation [Mental Process]

Phrase: "may"

Phrase: "function by directly activating cells of the innate immune system"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   764   C2346474:Immune Cell Function [Research Activity]
   760   C0020962:Immune system [Body System]
   760   C1291764:IMMUNE SYSTEM [Finding]
   757   C0007613:cells function [Cell Function]
   757   C1817756:Immune Function [Organ or Tissue Function]
   739   C0007634:Cells [Cell]
   739   C0031843:function [Physiologic Function]
   739   C0439662:Immune [Functional Concept]
   739   C0449913:System [Functional Concept]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1553451:System [Manufactured Object]
   739   C1704459:System [Medical Device]
   739   C1705273:Function [Intellectual Product]
   739   C1879547:activating [Activity]
   739   C1947931:Directly [Qualitative Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1515877:Activate [Functional Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "(21). Such ""natural allergens,"" which also elicit sensitization in human subjects, may function by directly activating cells of the innate immune system (APCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "and"

Phrase: "mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "(APCs and mast cells) (21,"

Phrase: "22"

Phrase: ")"

Phrase: ","

Phrase: "thus fulfilling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550543:Fulfill [Idea or Concept]

Phrase: "the functions of both adjuvants"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "antigens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.67: Protocols using protease allergens may thus induce certain functions of the innate immune system that modify the nature of the subsequent immune response, and that may be missing in protocols that use OVA as an antigen. 

Phrase: "Protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protease allergens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002092:Allergens [Immunologic Factor]
   861   C0802014:Allergens [Clinical Attribute]
   827 E C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "thus"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "certain functions of the innate immune system"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C1817756:Immune Function [Organ or Tissue Function]
   748   C0542341:Functions [Functional Concept]
   732   C1180473:Functional system [Body System]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the nature of the subsequent immune response,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "missing in protocols"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0442711:Protocols [Intellectual Product]
   790   C1551393:Missing [Idea or Concept]
   790   C1705492:Missing [Qualitative Concept]
   790   C3272743:MISSING [Qualitative Concept]
   756 E C1507394:Protocol [Intellectual Product]
   756 E C1522729:Protocol [Intellectual Product]
   756 E C2348563:Protocol [Intellectual Product]
   756 E C2349206:Miss [Conceptual Entity]

Phrase: "that"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "OVA as an antigen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.68: Conundrums: contributions of eosinophils and mast cells Eosinophils and mast cells are main effector cells of Th2-polarized immune defenses of the mouse against helminthic parasites such as Trichinella spiralis. 

Phrase: "Conundrums"

Phrase: ":"

Phrase: "contributions of eosinophils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "mast cells Eosinophils"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   827   C0014467:Eosinophils [Cell]
   827   C0200638:Eosinophils [Laboratory Procedure]
   743 E C0333930:Eosinophilic [Functional Concept]
   734   C0024880:Mast Cells [Cell]
   721 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   721 E C1306759:Eosinophilia [Disease or Syndrome]
   721 E C1636667:Eosinophilia [Disease or Syndrome]
   721 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "main effector cells of Th2-polarized immune defenses"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   797   C0242633:T-helper cell type 2 [Cell]
           Type 2 helper cell
   772   C0018894:cells t-helper [Cell]
           Helper Cells
   770   C3641722:Effector T Cells [Cell]
   759   C0449475:Type of cell [Intellectual Product]
           cells type
   755   C0312740:Immune effector cell [Cell]
           Effector Cell
   738   C0007634:Cells [Cell]
       E   Cell Type
   738   C3282337:Cells [Cell]
   737   C0598102:polarized cell [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "of the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "against helminthic parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]

Phrase: "such as Trichinella spiralis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040892:Trichinella spiralis [Eukaryote]
   861   C0040891:Trichinella [Eukaryote]
Processing 00000000.tx.69: Normal mouse lung contains no eosinophils and sparse numbers of mast cells, which are confined to the paratracheal tissues. 

Phrase: "Normal mouse lung"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C1518039:Mouse Lung [Tissue]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0819757:LUNG [Tissue]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "no eosinophils"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014467:Eosinophils [Cell]
  1000   C0200638:Eosinophils [Laboratory Procedure]
   916 E C0333930:Eosinophilic [Functional Concept]
   893 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   893 E C1306759:Eosinophilia [Disease or Syndrome]
   893 E C1636667:Eosinophilia [Disease or Syndrome]
   893 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "sparse numbers of mast cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "confined to the paratracheal tissues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040300:Tissues [Tissue]
   760   C0442143:Paratracheal [Spatial Concept]
   726 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.70: In OVA-induced pulmonary inflammation, sharp increases in tissue eosinophils reflect their recruitment as mature cells from peripheral blood, while a modest reactive intraepithelial mast cell hyperplasia (23) is attributable to the comitogenic effects of Th2 cell cytokines that synergize with the homeostatic mast cell growth factor, stem cell factor. 

Phrase: "In OVA-induced pulmonary inflammation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032285:Pulmonary Inflammation [Disease or Syndrome]
   812   C0021368:Inflammation [Pathologic Function]

Phrase: "sharp increases in tissue eosinophils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "their recruitment as mature cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2949735:Recruitment [Activity]

Phrase: "from peripheral blood,"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "while"

Phrase: "a modest reactive intraepithelial mast cell hyperplasia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   876   C0333979:Reactive hyperplasia [Pathologic Function]
   861   C0024899:Mast cell hyperplasia [Disease or Syndrome]
   799   C0020507:Hyperplasia [Pathologic Function]

Phrase: "(21, 22), thus fulfilling the functions of both adjuvants and antigens. Protocols using protease allergens may thus induce certain functions of the innate immune system that modify the nature of the subsequent immune response, and that may be missing in protocols that use OVA as an antigen. Conundrums: contributions of eosinophils and mast cells Eosinophils and mast cells are main effector cells of Th2-polarized immune defenses of the mouse against helminthic parasites such as Trichinella spiralis. Normal mouse lung contains no eosinophils and sparse numbers of mast cells, which are confined to the paratracheal tissues. In OVA-induced pulmonary inflammation, sharp increases in tissue eosinophils reflect their recruitment as mature cells from peripheral blood, while a modest reactive intraepithelial mast cell hyperplasia (23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "attributable to the comitogenic effects of Th2 cell cytokines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0596130:Attributable [Mental Process]

Phrase: "that"

Phrase: "synergize with the homeostatic mast cell growth factor,"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   833   C0021757:Mast-Cell Growth Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0143630:Mast Cell Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334117:mast-cell growth factor [Gene or Genome]
   833   C1366480:MAST CELL GROWTH FACTOR [Gene or Genome]
   833   C1526982:Mast Cell Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0007595:Cell Growth [Cell Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0024880:mast cell [Cell]
   757   C2246410:mast cell homeostasis [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0019868:homeostatic [Biologic Function]
   744   C0220844:growth [Physiologic Function]
   744   C0451297:MAST [Intellectual Product]
   744   C0684269:mast- [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1521761:Factor [Functional Concept]
   744   C1539838:MAST [Gene or Genome]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "stem cell factor."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0143630:Stem Cell Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1521761:Factor [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.71: The specific contribution of each cell type to the pathophysiology of OVA-induced models remains a subject of considerable debate. 

Phrase: "The specific contribution of each cell type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "to the pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "of OVA-induced models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "remains"

Phrase: "a subject of considerable debate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
Processing 00000000.tx.72: Mice lacking IL-5 (24) or IL-5 and eotaxin-1 (25) exhibit attenuated OVA-induced pulmonary eosinophil recruitment and impaired induction of AHR (24, 25), goblet cell metaplasia (24), and production of IL-13 by CD4+ T cells ex vivo (25). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "IL-5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334121:interleukin-5 [Gene or Genome]
  1000   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(23) is attributable to the comitogenic effects of Th2 cell cytokines that synergize with the homeostatic mast cell growth factor, stem cell factor. The specific contribution of each cell type to the pathophysiology of OVA-induced models remains a subject of considerable debate. Mice lacking IL-5 (24"

Phrase: ")"

Phrase: "or"

Phrase: "IL-5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334121:interleukin-5 [Gene or Genome]
  1000   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "eotaxin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0250604:Eotaxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Eotaxin
  1000   C1332676:eotaxin-1 [Gene or Genome]
           EOTAXIN
   861   C1527022:Eotaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(24) or IL-5 and eotaxin-1 (25"

Phrase: ")"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "attenuated OVA-induced pulmonary eosinophil recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2949735:Recruitment [Activity]

Phrase: "and"

Phrase: "impaired induction of AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(25) exhibit attenuated OVA-induced pulmonary eosinophil recruitment and impaired induction of AHR (24,"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "goblet cell metaplasia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0025568:Metaplasia [Cell or Molecular Dysfunction]
   755 E C0334023:Metaplastic [Functional Concept]
   734   C0506994:Goblet cell [Cell]

Phrase: "(24, 25), goblet cell metaplasia (24"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "production of IL-13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1819440:interleukin-13 production [Organism Function]
   819   C3159141:interleukin production [Organism Function]
   770   C0033268:production [Occupational Activity]

Phrase: "by CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "ex vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]

Phrase: "(24), and production of IL-13 by CD4+ T cells ex vivo (25"

Phrase: "), and production of IL-13 by CD4+ T cells ex vivo (25)."
Processing 00000000.tx.73: In contrast, a strain lacking CCR3, an essential chemokine receptor for eosinophil recruitment, showed no pulmonary eosinophil recruitment, but unimpaired induction of AHR and goblet cell metaplasia (26). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a strain lacking CCR3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1413189:CCR3 [Gene or Genome]

Phrase: "an essential chemokine receptor for eosinophil recruitment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no pulmonary eosinophil recruitment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2949735:Recruitment [Activity]

Phrase: "but"

Phrase: "unimpaired induction of AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "goblet cell metaplasia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0025568:Metaplasia [Cell or Molecular Dysfunction]
   755 E C0334023:Metaplastic [Functional Concept]
   734   C0506994:Goblet cell [Cell]

Phrase: "(25). In contrast, a strain lacking CCR3, an essential chemokine receptor for eosinophil recruitment, showed no pulmonary eosinophil recruitment, but unimpaired induction of AHR and goblet cell metaplasia (26"

Phrase: "). In contrast, a strain lacking CCR3, an essential chemokine receptor for eosinophil recruitment, showed no pulmonary eosinophil recruitment, but unimpaired induction of AHR and goblet cell metaplasia (26)."
Processing 00000000.tx.74: Conflicting data were obtained in studies where depletion of eosinophils was accomplished by blocking antibodies to IL-5 (8, 27). 

Phrase: "Conflicting data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained in studies where depletion of eosinophils"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0014467:Eosinophils [Cell]
   748   C0200638:Eosinophils [Laboratory Procedure]
   748   C0333668:Depletion [Functional Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1301820:Obtained [Functional Concept]
   728   C0014457:EOSINOPHILS INCREASED [Disease or Syndrome]
   714 E C0557651:Study [Manufactured Object]
   714 E C1706701:Obtain [Activity]
   714 E C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "accomplished by blocking antibodies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0282682:Antibodies, Blocking [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "to IL-5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334121:interleukin-5 [Gene or Genome]
  1000   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(26). Conflicting data were obtained in studies where depletion of eosinophils was accomplished by blocking antibodies to IL-5 (8,"

Phrase: "27"

Phrase: "). Conflicting data were obtained in studies where depletion of eosinophils was accomplished by blocking antibodies to IL-5 (8, 27)."
Processing 00000000.tx.75: Studies reporting a critical role for eosinophils in AHR have often used the comparatively weakly Th2-responding C57BL/6 mouse strain, or backcrosses to BALB/c from C57BL/6 (25), whereas several studies failing to show such requirements have been performed in strains with a BALB/c background (8, 26). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a critical role for eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the comparatively weakly Th2-responding C57BL/6 mouse strain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   788   C0080194:Strain [Injury or Poisoning]
   788   C0456178:strain [Intellectual Product]
   788   C1518614:Strain [Organism]
   788   C2987481:Strain [Mental Process]

Phrase: "or"

Phrase: "backcrosses to BALB/c"

Phrase: "from C57BL/6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: "(8, 27). Studies reporting a critical role for eosinophils in AHR have often used the comparatively weakly Th2-responding C57BL/6 mouse strain, or backcrosses to BALB/c from C57BL/6 (25"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "failing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:failing [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "such requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514873:Requirement [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "performed in strains"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0080194:Strains [Injury or Poisoning]
   790   C0456178:strains [Intellectual Product]
   790   C0884358:Performed [Functional Concept]
   756 E C1518614:Strain [Organism]
   756 E C2947996:Perform [Pharmacologic Substance]
   756 E C2987481:Strain [Mental Process]

Phrase: "with a BALB/c background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706907:Background [Conceptual Entity]
   734   C0025919:BALB/C [Mammal]

Phrase: "(25), whereas several studies failing to show such requirements have been performed in strains with a BALB/c background (8,"

Phrase: "26"

Phrase: "), whereas several studies failing to show such requirements have been performed in strains with a BALB/c background (8, 26)."
Processing 00000000.tx.76: Recently, experiments conducted on C57BL/6 mice deficient in eosinophils due to expression of diphtheria toxin A under control of an eosinophil-specific promoter revealed that induced AHR and goblet cell metaplasia required eosinophils (28). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "conducted on C57BL/6 mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   797   C0025921:Mice, C57BL [Mammal]
           C57BL
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   726   C0004927:Conduct [Individual Behavior]

Phrase: "deficient in eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011155:Deficient [Functional Concept]
   790   C1636779:% deficient [Quantitative Concept]

Phrase: "due to expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of diphtheria toxin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0012550:Diphtheria Toxin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0012546:DIPHTERIA [Disease or Syndrome]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of an eosinophil-specific promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that induced AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "goblet cell metaplasia required eosinophils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0014467:Eosinophils [Cell]
   804   C0200638:Eosinophils [Laboratory Procedure]
   721 E C0333930:Eosinophilic [Functional Concept]

Phrase: "(8, 26). Recently, experiments conducted on C57BL/6 mice deficient in eosinophils due to expression of diphtheria toxin A under control of an eosinophil-specific promoter revealed that induced AHR and goblet cell metaplasia required eosinophils (28"

Phrase: "). Recently, experiments conducted on C57BL/6 mice deficient in eosinophils due to expression of diphtheria toxin A under control of an eosinophil-specific promoter revealed that induced AHR and goblet cell metaplasia required eosinophils (28)."
Processing 00000000.tx.77: By contrast, BALB/c mice made deficient in eosinophils by deletion of a high-affinity GATA binding site in the GATA-1 promoter showed no requirement for eosinophils in either AHR or goblet cell metaplasia (29). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "deficient in eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011155:Deficient [Functional Concept]
   790   C1636779:% deficient [Quantitative Concept]

Phrase: "by deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "of a high-affinity GATA binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0005456:Binding Site [Receptor]
   840   C0682969:Binding Site [Amino Acid Sequence]
   804   C0205145:Site [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "in the GATA-1 promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no requirement for eosinophils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "in either AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "goblet cell metaplasia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0025568:Metaplasia [Cell or Molecular Dysfunction]
   755 E C0334023:Metaplastic [Functional Concept]
   734   C0506994:Goblet cell [Cell]

Phrase: "(28). By contrast, BALB/c mice made deficient in eosinophils by deletion of a high-affinity GATA binding site in the GATA-1 promoter showed no requirement for eosinophils in either AHR or goblet cell metaplasia (29"

Phrase: "). By contrast, BALB/c mice made deficient in eosinophils by deletion of a high-affinity GATA binding site in the GATA-1 promoter showed no requirement for eosinophils in either AHR or goblet cell metaplasia (29)."
Processing 00000000.tx.78: Interpretation of the role for eosinophils in mouse AHR is further complicated by the finding that very high levels of bronchial eosinophilia (driven by an IL-5 transgene) protected C3H/Hej mice against OVA-induced AHR, reflecting the provision of TGF-1 (30), a cytokine that can down-modulate Th2 responses. 

Phrase: "Interpretation of the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0459471:Interpretation [Intellectual Product]
   770   C3173575:Interpretation [Clinical Attribute]

Phrase: "for eosinophils"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014467:Eosinophils [Cell]
  1000   C0200638:Eosinophils [Laboratory Procedure]
   916 E C0333930:Eosinophilic [Functional Concept]
   893 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   893 E C1306759:Eosinophilia [Disease or Syndrome]
   893 E C1636667:Eosinophilia [Disease or Syndrome]
   893 E C2240374:Eosinophilia [Finding]

Phrase: "in mouse AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "complicated by the finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0231242:Complicated [Functional Concept]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]

Phrase: "that very high levels of bronchial eosinophilia"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "driven by an IL-5 transgene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1334121:interleukin-5 [Gene or Genome]
   790   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0282641:Transgene [Gene or Genome]
   753   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C0013126:Drive [Mental Process]

Phrase: ")"

Phrase: "protected C3H/Hej mice against OVA-induced AHR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C1511362:C3H/HeJ Mouse [Mammal]
   762   C0025920:Mice, C3H [Mammal]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the provision of TGF-1"

Phrase: "(driven by an IL-5 transgene) protected C3H/Hej mice against OVA-induced AHR, reflecting the provision of TGF-1 (30"

Phrase: ")"

Phrase: ","

Phrase: "a cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that"

Phrase: "can"

Phrase: "down-modulate"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205104:Down [Spatial Concept]
   861   C0443264:modulate [Spatial Concept]
   805 E C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805 E C2626739:Lanugo [Eukaryote]

Phrase: "Th2 responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]
Processing 00000000.tx.79: A critical observation in this study was that reduction of eosinophil numbers with an anti-IL-5 antibody amplified OVA-induced AHR, suggesting that the doseresponse curve relating eosinophils to AHR in mice may be bell-shaped. 

Phrase: "A critical observation in this study"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0552617:Study observation [Functional Concept]
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]
   748 E C1518527:Observational Study [Research Activity]

Phrase: "was"

Phrase: "that reduction of eosinophil numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "with an anti-IL-5 antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1334121:interleukin-5 [Gene or Genome]
   861   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "amplified"

Phrase: "OVA-induced AHR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0178987:Airway, NOS [Medical Device]
   812   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the doseresponse curve relating eosinophils to AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0014467:Eosinophils [Cell]
   744   C0200638:Eosinophils [Laboratory Procedure]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "be"

Phrase: "bell-shaped."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0332479:shaped [Spatial Concept]
   861   C0522512:shaped [Spatial Concept]
   861   C1706917:Bell [Manufactured Object]
   827 E C0348078:shape [Qualitative Concept]
Processing 00000000.tx.80: The inconsistencies regarding the role of eosinophils in the short-term models of airway disease are contrasted by the relatively consistent demonstration that eosinophils are required for remodeling in models using a longer period of allergen challenge (29, 31), possibly through pathways involving TGF-1 (31) and/or cysteinyl leukotrienes (32). 

Phrase: "The inconsistencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0442809:Inconsistent [Qualitative Concept]

Phrase: "regarding"

Phrase: "the role of eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the short-term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "models of airway disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0699949:airway disease [Disease or Syndrome]
   819   C0683033:disease model [Intellectual Product]
   819   C0684309:Disease model [Experimental Model of Disease]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0178987:Airway, NOS [Medical Device]
   770   C0458827:Airway [Body Part, Organ, or Organ Component]
   770   C3161035:Model [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "contrasted by the relatively consistent demonstration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332290:Consistent [Idea or Concept]
   753   C0449900:contrasted [Diagnostic Procedure]
   719 E C1979874:Contrast [Qualitative Concept]

Phrase: "that eosinophils"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014467:Eosinophils [Cell]
  1000   C0200638:Eosinophils [Laboratory Procedure]
   916 E C0333930:Eosinophilic [Functional Concept]
   893 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   893 E C1306759:Eosinophilia [Disease or Syndrome]
   893 E C1636667:Eosinophilia [Disease or Syndrome]
   893 E C2240374:Eosinophilia [Finding]

Phrase: "are"

Phrase: "required for remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "in models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a longer period of allergen challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439531:/period [Temporal Concept]
   753   C1948053:Period [Temporal Concept]
   742   C0425943:period length [Finding]

Phrase: "(30), a cytokine that can down-modulate Th2 responses. A critical observation in this study was that reduction of eosinophil numbers with an anti-IL-5 antibody amplified OVA-induced AHR, suggesting that the doseresponse curve relating eosinophils to AHR in mice may be bell-shaped. The inconsistencies regarding the role of eosinophils in the short-term models of airway disease are contrasted by the relatively consistent demonstration that eosinophils are required for remodeling in models using a longer period of allergen challenge (29,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "possibly through pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1704259:Pathways [Molecular Function]
   790   C1705987:Pathways [Conceptual Entity]
   790   C2362652:Possibly [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "TGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(29, 31), possibly through pathways involving TGF-1 (31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and/or"

Phrase: "cysteinyl leukotrienes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0675175:cysteinyl leukotrienes [Organic Chemical,Pharmacologic Substance]
   861   C0023545:Leukotrienes [Biologically Active Substance,Eicosanoid]

Phrase: "(31) and/or cysteinyl leukotrienes (32"

Phrase: ") and/or cysteinyl leukotrienes (32)."
Processing 00000000.tx.81: Mast cells generate and release numerous mediators (leukotrienes, prostaglandin D2, histamine, proteases, and cytokines) that potently modulate smooth muscle and/or Th2 responses, and contribute substantially to asthmatic early and late-phase responses to allergen challenge in humans. 

Phrase: "Mast cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "generate"

Phrase: "and"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "numerous mediators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(32). Mast cells generate and release numerous mediators (leukotrienes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023545:Leukotrienes [Biologically Active Substance,Eicosanoid]

Phrase: "prostaglandin D2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0033532:Prostaglandin D2 [Biologically Active Substance,Eicosanoid]
  1000   C3541268:Prostaglandin D2 [Laboratory Procedure]
   861   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   861   C1266240:Prostaglandin [Laboratory Procedure]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "histamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019588:Histamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "that potently"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "smooth muscle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1267092:Muscle, Smooth [Tissue]
   861   C0026845:Muscle [Tissue]
   861   C0205357:Smooth [Qualitative Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and/or"

Phrase: "Th2 responses,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "substantially to asthmatic early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004096:Asthmatic [Disease or Syndrome]
   770   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late-phase responses to allergen challenge"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0205087:Late [Temporal Concept]
   753   C0205390:Phase [Temporal Concept]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.82: The contribution of mast cells to the induction of AHR, eosinophilia, or both in mice depends on the strength of OVA sensitization and challenge protocols. 

Phrase: "The contribution of mast cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of AHR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "eosinophilia,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0014457:Eosinophilia [Disease or Syndrome]
  1000   C1306759:Eosinophilia [Disease or Syndrome]
  1000   C1636667:Eosinophilia [Disease or Syndrome]
  1000   C2240374:Eosinophilia [Finding]
   928 E C0333930:Eosinophilic [Functional Concept]
   900 E C0014467:Eosinophils [Cell]
   900 E C0200638:Eosinophils [Laboratory Procedure]

Phrase: "or"

Phrase: "both in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "depends on the strength of OVA sensitization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0237897:Strength [Quantitative Concept]
   748   C0725813:depend [Medical Device]
   748   C0808080:Strength [Idea or Concept]
   748   C1325847:Sensitisation [Mental Process]
   748   C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "challenge protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.83: Intraperitoneal sensitization to OVA without alum, sensitization with OVA/alum followed by a minimal number of airway challenges, or weak sensitization induced only by successive intranasal challenge with OVA (33) each reveal substantial contributions from mast cells to the effector phase. 

Phrase: "Intraperitoneal sensitization to OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1325847:Sensitisation [Mental Process]

Phrase: "without alum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]

Phrase: "sensitization with OVA/alum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1325847:Sensitisation [Mental Process]

Phrase: "followed by a minimal number of airway challenges,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0178987:Airway, NOS [Medical Device]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0458827:Airway [Body Part, Organ, or Organ Component]
   744   C0547040:Minimal [Qualitative Concept]
   744   C0805586:challenges [Health Care Activity]
   744   C1524031:MINIMAL [Qualitative Concept]
   744   C2945599:Minimal [Qualitative Concept]
   711 E C0798503:Challenge [Clinical Attribute]
   711 E C1719822:Follow [Intellectual Product]
   711 E C3274764:Challenge [Conceptual Entity]

Phrase: "or"

Phrase: "weak sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1325847:Sensitisation [Mental Process]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "only by successive intranasal challenge"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205171:Only [Quantitative Concept]
   760   C0442118:Intranasal [Spatial Concept]
   760   C0798503:Challenge [Clinical Attribute]
   760   C0805586:Challenge [Health Care Activity]
   760   C1720467:Only [Intellectual Product]
   760   C3274764:Challenge [Conceptual Entity]

Phrase: "with OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(leukotrienes, prostaglandin D2, histamine, proteases, and cytokines) that potently modulate smooth muscle and/or Th2 responses, and contribute substantially to asthmatic early and late-phase responses to allergen challenge in humans. The contribution of mast cells to the induction of AHR, eosinophilia, or both in mice depends on the strength of OVA sensitization and challenge protocols. Intraperitoneal sensitization to OVA without alum, sensitization with OVA/alum followed by a minimal number of airway challenges, or weak sensitization induced only by successive intranasal challenge with OVA (33"

Phrase: ")"

Phrase: "each"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "substantial contributions from mast cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "to the effector phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.84: Although strong systemic sensitization or higher-dose airway challenges override the window for detecting a mast cell contribution, there is direct evidence that IgE-dependent mast cell activation induces AHR in naive mice without OVA-induced pulmonary inflammation (34), and potentiates OVA-induced AHR in actively sensitized mice (35). 

Phrase: "Although"

Phrase: "strong systemic sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1325847:Sensitisation [Mental Process]

Phrase: "or"

Phrase: "higher-dose airway challenges"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0805586:challenges [Health Care Activity]
   779 E C0798503:Challenge [Clinical Attribute]
   779 E C3274764:Challenge [Conceptual Entity]

Phrase: "override"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Over-ride [Activity]

Phrase: "the window for detecting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557702:Window [Manufactured Object]
   770   C1272706:Window [Temporal Concept]
   770   C1704674:Window [Manufactured Object]

Phrase: "a mast cell contribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1880177:Contribution [Activity]
   734   C0024880:mast cell [Cell]

Phrase: "there"

Phrase: "is"

Phrase: "direct evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that IgE-dependent mast cell activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1155074:mast cell activation [Cell Function]
   840   C1326120:cell activation [Cell Function]
   804   C1879547:Activation [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "AHR in naive mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178987:Airway, NOS [Medical Device]
   760   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "without OVA-induced pulmonary inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032285:Pulmonary Inflammation [Disease or Syndrome]
   812   C0021368:Inflammation [Pathologic Function]

Phrase: "(33) each reveal substantial contributions from mast cells to the effector phase. Although strong systemic sensitization or higher-dose airway challenges override the window for detecting a mast cell contribution, there is direct evidence that IgE-dependent mast cell activation induces AHR in naive mice without OVA-induced pulmonary inflammation (34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "potentiates"

Phrase: "OVA-induced AHR in actively sensitized mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0178987:Airway, NOS [Medical Device]
   744   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "(34), and potentiates OVA-induced AHR in actively sensitized mice (35"

Phrase: "), and potentiates OVA-induced AHR in actively sensitized mice (35)."
Processing 00000000.tx.85: Furthermore, both C57BL/6 (35) and BALB/c mice (34) lacking FcRI show deficits in AHR in weak sensitization and challenge protocols, reflecting amplification by mast cells of afferent and/or efferent events. 

Phrase: "Furthermore,"

Phrase: "both C57BL/6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: "(35). Furthermore, both C57BL/6 (35"

Phrase: ")"

Phrase: "and"

Phrase: "BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(35) and BALB/c mice (34"

Phrase: ")"

Phrase: "lacking FcRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541895:FCRI [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "deficits in AHR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "in weak sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1325847:Sensitisation [Mental Process]

Phrase: "and"

Phrase: "challenge protocols,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "amplification by mast cells of afferent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and/or"

Phrase: "efferent events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]
Processing 00000000.tx.86: Mast cell infiltration of airway smooth muscle, a major correlate of human AHR and asthma in humans (3), has not yet been modeled in mice. 

Phrase: "Mast cell infiltration of airway smooth muscle,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C3278453:Mast cell infiltration [Finding]
   748   C0332448:Infiltration [Pathologic Function]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]

Phrase: "a major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "correlate of human AHR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086418:Human [Human]
   760   C0178987:Airway, NOS [Medical Device]
   760   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "asthma in humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004096:Asthma [Disease or Syndrome]
   790   C2984299:Asthma [Functional Concept]

Phrase: "(34) lacking FcRI show deficits in AHR in weak sensitization and challenge protocols, reflecting amplification by mast cells of afferent and/or efferent events. Mast cell infiltration of airway smooth muscle, a major correlate of human AHR and asthma in humans (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "modeled in mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   824   C2986594:Mouse Model [Experimental Model of Disease]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   756   C3161035:Model [Intellectual Product]
Processing 00000000.tx.87: Implications of mouse models for the pathophysiology of asthma No truly authentic "asthmatic mouse" exists, and the available models used currently cannot dissect the complex mechanisms of spontaneous and variable airflow obstruction, disease exacerbations, or naive AHR. 

Phrase: "Implications of mouse"

Phrase: "models for the pathophysiology of asthma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0004096:Asthma [Disease or Syndrome]
   753   C0031847:pathophysiology [Functional Concept]
   753   C0277785:Pathophysiology [Qualitative Concept]
   753   C2984299:Asthma [Functional Concept]
   753   C3161035:Model [Intellectual Product]

Phrase: "No truly authentic ""asthmatic mouse"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "the available models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "cannot"

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "the complex mechanisms of spontaneous"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "variable airflow obstruction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0028778:Obstruction [Pathologic Function]
   827   C1882136:OBSTRUCTION [Phenomenon or Process]

Phrase: "disease exacerbations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   983   C0235874:Disease Exacerbation [Finding]

Phrase: "or"

Phrase: "naive AHR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.88: However, the allergen-induced models have proven invaluable for dissection of afferent innate and adaptive mechanisms leading to sensitization, and efferent mechanisms for effector cell and end-organ responses (Table I). 

Phrase: "However,"

Phrase: "the allergen-induced models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "proven invaluable for dissection of afferent innate"

Phrase: "and"

Phrase: "adaptive mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to sensitization,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0332152:Leading [Temporal Concept]
   790   C1325847:Sensitisation [Mental Process]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "efferent mechanisms for effector cell"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "end-organ responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "(3), has not yet been modeled in mice. Implications of mouse models for the pathophysiology of asthma No truly authentic ""asthmatic mouse"" exists, and the available models used currently cannot dissect the complex mechanisms of spontaneous and variable airflow obstruction, disease exacerbations, or naive AHR. However, the allergen-induced models have proven invaluable for dissection of afferent innate and adaptive mechanisms leading to sensitization, and efferent mechanisms for effector cell and end-organ responses (Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "), has not yet been modeled in mice. Implications of mouse models for the pathophysiology of asthma No truly authentic ""asthmatic mouse"" exists, and the available models used currently cannot dissect the complex mechanisms of spontaneous and variable airflow obstruction, disease exacerbations, or naive AHR. However, the allergen-induced models have proven invaluable for dissection of afferent innate and adaptive mechanisms leading to sensitization, and efferent mechanisms for effector cell and end-organ responses (Table I)."
Processing 00000000.tx.89: Extrapolation of these mechanisms to the pathophysiology of human disease, and to the development of potential pharmacotherapeutic targets, requires caution as the models introduce the potential bias of genetic purity that may not translate to human populations. 

Phrase: "Extrapolation of these mechanisms"

Phrase: "to the pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "of human disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and to the development of potential pharmacotherapeutic targets,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0013217:pharmacotherapeutic [Functional Concept]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1515981:And [Idea or Concept]
   744   C1527148:Development [Functional Concept]
   744   C3245505:Potential [Qualitative Concept]
   711   C1521840:Target [Functional Concept]
   711   C2986546:TARGET [Diagnostic Procedure]

Phrase: "requires"

Phrase: "caution as the models"

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "the potential bias of genetic purity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0242568:Bias [Idea or Concept]
   753   C1504315:Bias [Bird]
   719 E C1061346:Bia [Eukaryote]
   719 E C1704746:BIA [Diagnostic Procedure]

Phrase: "that"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "translate to human populations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032659:Population [Quantitative Concept]
   770   C0040710:translate [Occupational Activity]
   770   C0086418:Human [Human]
   770   C1257890:Population [Population Group]
Processing 00000000.tx.90: Furthermore, such extrapolation must account for distinctions between mediators, cells, and receptors that are crucial for sensitization from those that amplify effector responses or contribute to their resolution or perpetuation. 

Phrase: "Furthermore,"

Phrase: "such extrapolation"

Phrase: "must"

Phrase: "account for distinctions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]

Phrase: "between mediators,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   966 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "are"

Phrase: "crucial for sensitization"

Phrase: "from those"

Phrase: "that"

Phrase: "amplify"

Phrase: "effector responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "contribute to their resolution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C1880177:Contribute [Activity]
   770   C2699488:Resolution [Conceptual Entity]

Phrase: "or"

Phrase: "perpetuation."
Processing 00000000.tx.91: The failure of a soluble recombinant form of the IL-4 receptor extracellular domain administered by inhalation to substantially improve asthma control (36) may relate to the central involvement of IL-4 in inductive events, but not effector events, especially induced AHR as shown in mice. 

Phrase: "The failure of a soluble recombinant form of the IL-4 receptor extracellular domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0231174:Failure [Functional Concept]
   734   C0680095:failure [Individual Behavior]

Phrase: "administered by inhalation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0004048:Inhalation [Organism Function]
   790   C0205535:Inhalation [Functional Concept]
   790   C1521801:Administered [Functional Concept]
   790   C1705211:Inhalation [Quantitative Concept]
   756 E C1621583:Administer [Functional Concept]

Phrase: "to substantially"

Phrase: "improve"

Phrase: "asthma control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Table I). Extrapolation of these mechanisms to the pathophysiology of human disease, and to the development of potential pharmacotherapeutic targets, requires caution as the models introduce the potential bias of genetic purity that may not translate to human populations. Furthermore, such extrapolation must account for distinctions between mediators, cells, and receptors that are crucial for sensitization from those that amplify effector responses or contribute to their resolution or perpetuation. The failure of a soluble recombinant form of the IL-4 receptor extracellular domain administered by inhalation to substantially improve asthma control (36"

Phrase: ")"

Phrase: "may"

Phrase: "relate to the central involvement of IL-4"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1334119:INTERLEUKIN 4 [Gene or Genome]
   770   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0163712:Relate [Organic Chemical]
   744   C0205099:Central [Spatial Concept]
   744   C1314939:Involvement [Functional Concept]
   744   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C1879652:Central - [Laboratory Procedure]

Phrase: "in inductive events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "but"

Phrase: "not effector events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "especially induced AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0178987:Airway, NOS [Medical Device]
   812   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "shown in mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.92: Although monoclonal antiIL-5 antibodies blunt peripheral blood and sputum eosinophil counts in human asthmatics, they do not alter impaired airflow or AHR, a finding some mouse strains. 

Phrase: "Although"

Phrase: "monoclonal antiIL-5 antibodies blunt peripheral blood"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   818   C0229664:peripheral blood [Body Substance]
           Blood
   795   C0005767:Blood [Tissue]
   795   C0005768:blood [Body Substance]
   795   C0205100:Peripheral [Spatial Concept]
   776 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   724 E C0333275:Bloody [Qualitative Concept]
   712 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   712 E C0392895:Bloods [Population Group]
   712 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   712 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "sputum eosinophil"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   950   C0241234:SPUTUM EOSINOPHILIA [Finding]
   861   C0014467:eosinophil [Cell]
   789 E C0333930:Eosinophilic [Functional Concept]
   761 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   761 E C1306759:Eosinophilia [Disease or Syndrome]
   761 E C1636667:Eosinophilia [Disease or Syndrome]
   761 E C2240374:Eosinophilia [Finding]

Phrase: "counts in human asthmatics,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004096:asthmatics [Disease or Syndrome]
   770   C0086418:Human [Human]
   770   C0439157:counts [Quantitative Concept]
   770   C0750480:Count [Activity]
   770   C1705566:Count [Quantitative Concept]

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "impaired airflow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231999:Airflow [Physiologic Function]

Phrase: "or"

Phrase: "AHR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "some mouse strains."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1513684:Mouse Strains [Mammal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]
Processing 00000000.tx.93: The additional finding that prolonged (3 month) administration of antiIL-5 to a small group of humans with asthma decreased several indices of remodeling (36) would seem to reflect a broadly applicable, central role for eosinophils in a process that can readily be reproduced in mice. 

Phrase: "The additional finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that prolonged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439590:Prolonged [Temporal Concept]

Phrase: "(36) may relate to the central involvement of IL-4 in inductive events, but not effector events, especially induced AHR as shown in mice. Although monoclonal antiIL-5 antibodies blunt peripheral blood and sputum eosinophil counts in human asthmatics, they do not alter impaired airflow or AHR, a finding some mouse strains. The additional finding that prolonged (3 month"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439231:month [Temporal Concept]
   861   C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "administration of antiIL-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to a small group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0679993:small group [Group Attribute]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "with asthma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004096:Asthma [Disease or Syndrome]
  1000   C2984299:Asthma [Functional Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "several indices of remodeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0918012:Index [Intellectual Product]
   737   C1552854:index [Idea or Concept]
   737   C1637833:% index [Quantitative Concept]

Phrase: "(3 month) administration of antiIL-5 to a small group of humans with asthma decreased several indices of remodeling (36"

Phrase: ")"

Phrase: "would"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a broadly applicable, central role for eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "can"

Phrase: "readily"

Phrase: "be"

Phrase: "reproduced in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
Processing 00000000.tx.94: The fact that nonanaphylactogenic humanized monoclonal antibodies to the FcRI binding site of human IgE improve asthma control in atopic subjects (36) suggests that further manipulations of mast celldependent models may prove valuable for determining mechanisms of disease exacerbations. 

Phrase: "The fact"

Phrase: "that nonanaphylactogenic humanized monoclonal antibodies to the FcRI binding site of human IgE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   766   C2985546:Antibodies, Monoclonal, Humanized [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Antibodies, Humanized
   750   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   749   C0370238:IgE.monoclonal [Amino Acid, Peptide, or Protein,Immunologic Factor]
   747   C0005457:Antibody binding site [Immunologic Factor,Receptor]
   735   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   735   C0746619:monoclonal [Finding]
   732   C2754973:IgE antibody [Cell Component]
   702 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "improve"

Phrase: "asthma control in atopic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(36) would seem to reflect a broadly applicable, central role for eosinophils in a process that can readily be reproduced in mice. The fact that nonanaphylactogenic humanized monoclonal antibodies to the FcRI binding site of human IgE improve asthma control in atopic subjects (36"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that further manipulations of mast celldependent models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   748   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "prove"

Phrase: "valuable for determining mechanisms of disease exacerbations."
Processing 00000000.tx.95: The evidence implicating IL-13 as a central effector of both induced AHR and remodeling responses in the mouse awaits validation using pharmacologic antagonists in human asthma. 

Phrase: "The evidence implicating IL-13 as a central effector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "of both induced AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "remodeling responses in the mouse"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "awaits"

Phrase: "validation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519941:Validation [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pharmacologic antagonists in human asthma."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243076:antagonists [Chemical Viewed Functionally]
   726 E C0231491:Antagonist [Organ or Tissue Function]
Processing 00000000.tx.96: Finally, the accumulating body of evidence suggests that the A/J mouse provides an opportunity to study the influence of major genes, localized but yet to be identified, on constitutive AHR and susceptibility to chronic Th2 celllike bronchial inflammation with remodeling. 

Phrase: "Finally,"

Phrase: "the accumulating body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the A/J mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1510707:A/J Mouse [Mammal]
           A/J
   913   C1522424:A Mouse [Mammal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "an opportunity to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the influence of major genes,"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "but"

Phrase: "yet to"

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "on constitutive AHR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178987:Airway, NOS [Medical Device]
   827   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "susceptibility to chronic Th2 celllike bronchial inflammation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0012655:Susceptibility [Clinical Attribute]
   739   C0220898:Susceptibility [Organism Attribute]
   739   C1264642:Susceptibility [Functional Concept]
   739   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "with remodeling."
Processing 00000000.tx.97: View this table: [in this window] [in a new window]  Table I. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.98: Pathologic features of mouse models of allergen-induced pulmonary disease and human asthma  References Robinson, D.S., Q. 

Phrase: "Pathologic features of mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "models of allergen-induced pulmonary disease"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0024115:Pulmonary Disease [Disease or Syndrome]
   783   C0683033:disease model [Intellectual Product]
   783   C0684309:Disease model [Experimental Model of Disease]
   753   C0002092:Allergen [Immunologic Factor]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   753   C0205263:Induced [Functional Concept]
   753   C2707265:Pulmonary [Clinical Attribute]
   753   C2709248:Pulmonary [Qualitative Concept]
   753   C3161035:Model [Intellectual Product]
   753   C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "human asthma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004096:Asthma [Disease or Syndrome]
   861   C2984299:Asthma [Functional Concept]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Q."
Processing 00000000.tx.99: Hamid, S. 

Phrase: "Hamid,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.100: Ying, A. 

Phrase: "Ying,"

Phrase: "A."
Processing 00000000.tx.101: Tsicopoulos, J. 

Phrase: "Tsicopoulos,"

Phrase: "J."
Processing 00000000.tx.102: Barkans, A.M. 

Phrase: "Barkans,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.103: Bentley, C. 

Phrase: "Bentley,"

Phrase: "C."
Processing 00000000.tx.104: Corrigan, S.R. 

Phrase: "Corrigan,"

Phrase: "S.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.105: Durham, and A.B. 

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "and"

Phrase: "A.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]
Processing 00000000.tx.106: Kay. 

Phrase: "Kay."
Processing 00000000.tx.107: 1992. 

Phrase: "1992."
Processing 00000000.tx.108: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. 

Phrase: "Predominant TH2-like bronchoalveolar T-lymphocyte population"

Phrase: "in atopic asthma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0155877:Atopic asthma [Disease or Syndrome]
   861   C0004096:Asthma [Disease or Syndrome]
   861   C0392707:atopic [Pathologic Function]
   861   C2984299:Asthma [Functional Concept]
Processing 00000000.tx.109: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.110: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.111: J. 

Phrase: "J."
Processing 00000000.tx.112: Med. 

Phrase: "Med."
Processing 00000000.tx.113: 326:298304.[Abstract] Carroll, N.G., S. 

Phrase: "326"

Phrase: ":"

Phrase: "298304."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Carroll,"

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.114: Mutavdzic, and A.L. 

Phrase: "Mutavdzic,"

Phrase: "and"

Phrase: "A.L."
Processing 00000000.tx.115: James. 

Phrase: "James."
Processing 00000000.tx.116: 2002. 

Phrase: "2002."
Processing 00000000.tx.117: Distribution and degranulation of airway mast cells in normal and asthmatic subjects. 

Phrase: "Distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "degranulation of airway mast cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1622891:Mast cell degranulation [Cell Function]
   781   C0007588:Cell Degranulation [Cell Function]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "asthmatic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.118: Eur. 

Phrase: "Eur."
Processing 00000000.tx.119: Resp. 

Phrase: "Resp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231832:RESP [Clinical Attribute]
Processing 00000000.tx.120: J. 

Phrase: "J."
Processing 00000000.tx.121: 19:879885.[Abstract/Free FullText] Brightling, C.E., P. 

Phrase: "19"

Phrase: ":"

Phrase: "879885."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brightling,"

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.122: Bradding, F.A. 

Phrase: "Bradding,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.123: Symon, S.T. 

Phrase: "Symon,"

Phrase: "S."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.124: Holgate, A.J. 

Phrase: "Holgate,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.125: Wardlaw, and I.D. 

Phrase: "Wardlaw,"

Phrase: "and"

Phrase: "I.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0152277:i d [Therapeutic or Preventive Procedure]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.126: Pavord. 

Phrase: "Pavord."
Processing 00000000.tx.127: 2002. 

Phrase: "2002."
Processing 00000000.tx.128: Mast-cell infiltration of airway smooth muscle in asthma. 

Phrase: "Mast-cell infiltration of airway smooth muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C3278453:Mast cell infiltration [Finding]
   748   C0332448:Infiltration [Pathologic Function]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]

Phrase: "in asthma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004096:Asthma [Disease or Syndrome]
  1000   C2984299:Asthma [Functional Concept]
Processing 00000000.tx.129: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.130: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.131: J. 

Phrase: "J."
Processing 00000000.tx.132: Med. 

Phrase: "Med."
Processing 00000000.tx.133: 346:16991705.[Abstract/Free FullText] Hopp, R.J., R.G. 

Phrase: "346"

Phrase: ":"

Phrase: "16991705."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hopp,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.134: Townley, R.E. 

Phrase: "Townley,"

Phrase: "R.E."
Processing 00000000.tx.135: Biven, A.K. 

Phrase: "Biven,"

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.136: Bewtra, and N.M. 

Phrase: "Bewtra,"

Phrase: "and"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.137: Nair. 

Phrase: "Nair."
Processing 00000000.tx.138: 1990. 

Phrase: "1990."
Processing 00000000.tx.139: The presence of airway reactivity before the development of asthma. 

Phrase: "The presence of airway reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "before the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of asthma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004096:Asthma [Disease or Syndrome]
  1000   C2984299:Asthma [Functional Concept]
Processing 00000000.tx.140: Am. 

Phrase: "Am."
Processing 00000000.tx.141: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.142: Respir. 

Phrase: "Respir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205535:RESPIR [Functional Concept]
Processing 00000000.tx.143: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.144: 141:28.[Medline] Paggiaro, P.L., F.L. 

Phrase: "141"

Phrase: ":"

Phrase: "28."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paggiaro,"

Phrase: "P.L., F.L."
Processing 00000000.tx.145: Dente, M.C. 

Phrase: "Dente,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.146: Morelli, L. 

Phrase: "Morelli,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.147: Bancalari, A. 

Phrase: "Bancalari,"

Phrase: "A."
Processing 00000000.tx.148: Di Franco, D. 

Phrase: "Di Franco,"

Phrase: "D."
Processing 00000000.tx.149: Giannini, B. 

Phrase: "Giannini,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.150: Vagaggini, E. 

Phrase: "Vagaggini,"

Phrase: "E."
Processing 00000000.tx.151: Bacci, L.M. 

Phrase: "Bacci,"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.152: Fabbri, and C. 

Phrase: "Fabbri,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.153: Giuntini. 

Phrase: "Giuntini."
Processing 00000000.tx.154: 1994. 

Phrase: "1994."
Processing 00000000.tx.155: Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. 

Phrase: "Postallergen inhaled budesonide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0054201:Budesonide [Pharmacologic Substance,Steroid]

Phrase: "reduces"

Phrase: "late asthmatic response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0004096:Asthmatic [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the associated increase of airway responsiveness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "to methacholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600370:Methacholine [Organic Chemical,Pharmacologic Substance]

Phrase: "in asthmatics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004096:asthmatics [Disease or Syndrome]
Processing 00000000.tx.156: Am. 

Phrase: "Am."
Processing 00000000.tx.157: J. 

Phrase: "J."
Processing 00000000.tx.158: Respir. 

Phrase: "Respir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205535:RESPIR [Functional Concept]
Processing 00000000.tx.159: Crit. 

Phrase: "Crit."
Processing 00000000.tx.160: Care Med. 

Phrase: "Care Med."
Processing 00000000.tx.161: 149:14471451.[Abstract] Corry, D.B., G. 

Phrase: "149"

Phrase: ":"

Phrase: "14471451."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Corry,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.162: Grunig, H. 

Phrase: "Grunig,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.163: Hadeiba, V.P. 

Phrase: "Hadeiba,"

Phrase: "V.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1535597:v p [Therapeutic or Preventive Procedure]
Processing 00000000.tx.164: Kurup, M.L. 

Phrase: "Kurup,"

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.165: Warnock, D. 

Phrase: "Warnock,"

Phrase: "D."
Processing 00000000.tx.166: Sheppard, D.M. 

Phrase: "Sheppard,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.167: Rennick, and R.M. 

Phrase: "Rennick,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.168: Locksley. 

Phrase: "Locksley."
Processing 00000000.tx.169: 1998. 

Phrase: "1998."
Processing 00000000.tx.170: Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. 

Phrase: "Requirements for allergen-induced airway hyperreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1514873:Requirement [Functional Concept]

Phrase: "in T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "B cell-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.171: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.172: Med. 

Phrase: "Med."
Processing 00000000.tx.173: 4:344355.[CrossRef][Medline] Linehan, L.A., W.D. 

Phrase: "4"

Phrase: ":"

Phrase: "344355."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Linehan,"

Phrase: "L.A.,"

Phrase: "W.D."
Processing 00000000.tx.174: Warren, P.A. 

Phrase: "Warren,"

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.175: Thompson, M.J. 

Phrase: "Thompson,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.176: Grusby, and M.T. 

Phrase: "Grusby,"

Phrase: "and"

Phrase: "M.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.177: Berton. 

Phrase: "Berton."
Processing 00000000.tx.178: 1998. 

Phrase: "1998."
Processing 00000000.tx.179: STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. 

Phrase: "STAT6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0297890:STAT6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335877:STAT6 [Gene or Genome]

Phrase: "is"

Phrase: "required for IL-4-induced germline Ig gene transcription"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   810   C1539977:INTERLEUKIN 4-INDUCED GENE [Gene or Genome]
   784   C1334119:Interleukin 4 Gene [Gene or Genome]
           INTERLEUKIN 4
   784   C1708435:Interleukin-4 Gene [Gene or Genome]
   764   C0017350:Ig Gene [Gene or Genome]
   764   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C0040649:Gene Transcription [Genetic Function]
           Transcription
   764   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   762   C1334205:Interleukin Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0017473:Germ Line [Cell]
   742   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0205263:Induced [Functional Concept]
   742   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1514873:Required [Functional Concept]
   742   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C3541296:IG [Idea or Concept]

Phrase: "and"

Phrase: "switch recombination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512667:Switch Recombination [Genetic Function]
   861   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.180: J. 

Phrase: "J."
Processing 00000000.tx.181: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.182: 161:302310.[Abstract/Free FullText] Corry, D.B., H.G. 

Phrase: "161"

Phrase: ":"

Phrase: "302310."

Phrase: "[Abstract/Free FullText"

Phrase: "] Corry,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "H.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560020:h g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.183: Folkesson, M.L. 

Phrase: "Folkesson,"

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.184: Warnock, D.J. 

Phrase: "Warnock,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.185: Erle, M.A. 

Phrase: "Erle,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.186: Matthay, J.P. 

Phrase: "Matthay,"

Phrase: "J.P."
Processing 00000000.tx.187: Wiener-Kronish, and R.M. 

Phrase: "Wiener-Kronish,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.188: Locksley. 

Phrase: "Locksley."
Processing 00000000.tx.189: 1996. 

Phrase: "1996."
Processing 00000000.tx.190: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. 

Phrase: "Interleukin 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334119:INTERLEUKIN 4 [Gene or Genome]
  1000   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "but"

Phrase: "not interleukin 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1334121:interleukin-5 [Gene or Genome]
   901   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "eosinophils,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014467:Eosinophils [Cell]
  1000   C0200638:Eosinophils [Laboratory Procedure]
   916 E C0333930:Eosinophilic [Functional Concept]
   893 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   893 E C1306759:Eosinophilia [Disease or Syndrome]
   893 E C1636667:Eosinophilia [Disease or Syndrome]
   893 E C2240374:Eosinophilia [Finding]

Phrase: "is"

Phrase: "required in a murine model of acute airway hyperreactivity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0004096:Airway hyperreactivity [Disease or Syndrome]
   742   C0026809:Murine [Mammal]
   742   C0178987:Airway, NOS [Medical Device]
   742   C0205178:acute [Temporal Concept]
   742   C0458827:Airway [Body Part, Organ, or Organ Component]
   742   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   742   C1514873:Required [Functional Concept]
   742   C3161035:Model [Intellectual Product]
Processing 00000000.tx.191: J. 

Phrase: "J."
Processing 00000000.tx.192: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.193: Med. 

Phrase: "Med."
Processing 00000000.tx.194: 183:109117.[Abstract/Free FullText] Aversa, G., J. 

Phrase: "183"

Phrase: ":"

Phrase: "109117."

Phrase: "[Abstract/Free FullText"

Phrase: "] Aversa,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.195: Punnonen, B.G. 

Phrase: "Punnonen,"

Phrase: "B.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.196: Cocks, R. de Waal Malefyt, F. 

Phrase: "Cocks,"

Phrase: "R. de Waal Malefyt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.197: Vega Jr., S.M. 

Phrase: "Vega Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.198: Zurawski, G. 

Phrase: "Zurawski,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.199: Zurawski, and J.E. de Vries. 

Phrase: "Zurawski,"

Phrase: "and"

Phrase: "J.E. de Vries."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C3541240:DE [Idea or Concept]
Processing 00000000.tx.200: 1993. 

Phrase: "1993."
Processing 00000000.tx.201: An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. 

Phrase: "An interleukin 4 (IL-4) mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both IL-4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334119:INTERLEUKIN 4 [Gene or Genome]
  1000   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "IL-13-induced human immunoglobulin G4 (IgG4)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0020860:Immunoglobulin G4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0358321:Human immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C3537193:Human Immunoglobulin [Pharmacologic Substance]
   799   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C1621846:immunoglobulin [Molecular Function]

Phrase: "and"

Phrase: "IgE synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "B cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155008:B Cell Proliferation [Cell Function]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0004561:B-cell [Cell]

Phrase: ":"

Phrase: "support for a common component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0183683:Support [Medical Device]
   760   C1521721:Support [Conceptual Entity]

Phrase: "shared by IL-4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C1334119:INTERLEUKIN 4 [Gene or Genome]
   833   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0237876:shared [Social Behavior]
   770   C1522138:Shared [Functional Concept]
   770   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IL-13 receptors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0218229:Receptors, Interleukin-13 [Amino Acid, Peptide, or Protein,Receptor]
   913   C0206553:Receptors, Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.202: J. 

Phrase: "J."
Processing 00000000.tx.203: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.204: Med. 

Phrase: "Med."
Processing 00000000.tx.205: 178:22132218.[Abstract/Free FullText] Wills-Karp, M., J. 

Phrase: "178"

Phrase: ":"

Phrase: "22132218."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wills-Karp,"

Phrase: "M."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.206: Luyimbazi, X. 

Phrase: "Luyimbazi,"

Phrase: "X."
Processing 00000000.tx.207: Xu, B. 

Phrase: "Xu,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.208: Schofield, T.Y. 

Phrase: "Schofield,"

Phrase: "T.Y."
Processing 00000000.tx.209: Neben, C.L. 

Phrase: "Neben,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.210: Karp, and D.D. 

Phrase: "Karp,"

Phrase: "and"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.211: Donaldson. 

Phrase: "Donaldson."
Processing 00000000.tx.212: 1998. 

Phrase: "1998."
Processing 00000000.tx.213: Interleukin-13: central mediator of allergic asthma. 

Phrase: "Interleukin-13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "central mediator of allergic asthma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.214: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.215: 282:22582261.[Abstract/Free FullText] Mould, A.W., A.J. 

Phrase: "282"

Phrase: ":"

Phrase: "22582261."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mould,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0369241:Mold [Fungus]

Phrase: "A.W., A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C1510707:A/J [Mammal]
Processing 00000000.tx.216: Ramsay, K.I. 

Phrase: "Ramsay,"

Phrase: "K.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.217: Matthaei, I.G. 

Phrase: "Matthaei,"

Phrase: "I.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.218: Young, M.E. 

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.219: Rothenberg, and P.S. 

Phrase: "Rothenberg,"

Phrase: "and"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.220: Foster. 

Phrase: "Foster."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]
Processing 00000000.tx.221: 2000. 

Phrase: "2000."
Processing 00000000.tx.222: The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. 

Phrase: "The effect of IL-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "eotaxin expression in the lung"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on eosinophil"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0014467:eosinophil [Cell]
   928 E C0333930:Eosinophilic [Functional Concept]
   900 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   900 E C1306759:Eosinophilia [Disease or Syndrome]
   900 E C1636667:Eosinophilia [Disease or Syndrome]
   900 E C2240374:Eosinophilia [Finding]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "degranulation"

Phrase: "and"

Phrase: "the induction of bronchial hyperreactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.223: J. 

Phrase: "J."
Processing 00000000.tx.224: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.225: 164:21422150.[Abstract/Free FullText] Lee, C.G., R.J. 

Phrase: "164"

Phrase: ":"

Phrase: "21422150."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.226: Homer, Z. 

Phrase: "Homer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424986:HOMER [Gene or Genome]

Phrase: "Z."
Processing 00000000.tx.227: Zhu Z, S. 

Phrase: "Zhu Z,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.228: Lanone, X. 

Phrase: "Lanone,"

Phrase: "X."
Processing 00000000.tx.229: Wang, V. 

Phrase: "Wang,"

Phrase: "V."
Processing 00000000.tx.230: Koteliansky, J.M. 

Phrase: "Koteliansky,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.231: Shipley, P. 

Phrase: "Shipley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.232: Gotwals, P. 

Phrase: "Gotwals,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.233: Noble, Q. 

Phrase: "Noble,"

Phrase: "Q."
Processing 00000000.tx.234: Chen, R.M. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.235: Senior, and J.A. 

Phrase: "Senior,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705825:Senior [Idea or Concept]

Phrase: "and"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.236: Elias. 

Phrase: "Elias."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3623712:Elia [Eukaryote]
Processing 00000000.tx.237: 2001. 

Phrase: "2001."
Processing 00000000.tx.238: Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta 1. 

Phrase: "Interleukin-13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "tissue fibrosis by selectively stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016059:Fibrosis [Pathologic Function]

Phrase: "and"

Phrase: "activating transforming growth factor beta 1."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   947   C1366557:Transforming growth factor beta 1 [Gene or Genome]
   947   C1515406:Transforming Growth Factor-Beta 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   947   C1704256:Transforming Growth Factor Beta 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0330390:Beta [Plant]
   799   C0439096:Beta [Intellectual Product]
   799   C1510411:Transforming [Pathologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2004068:Beta [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
Processing 00000000.tx.239: J. 

Phrase: "J."
Processing 00000000.tx.240: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.241: Med. 

Phrase: "Med."
Processing 00000000.tx.242: 194:809-821.[Abstract/Free FullText] Bix, M., Z.E. 

Phrase: "194"

Phrase: ":"

Phrase: "809-821."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bix,"

Phrase: "M."

Phrase: ","

Phrase: "Z.E."
Processing 00000000.tx.243: Wang, B. 

Phrase: "Wang,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.244: Thiel, N.J. 

Phrase: "Thiel,"

Phrase: "N.J."
Processing 00000000.tx.245: Schork, and R.M. 

Phrase: "Schork,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.246: Locksley. 

Phrase: "Locksley."
Processing 00000000.tx.247: 1998. 

Phrase: "1998."
Processing 00000000.tx.248: Genetic regulation of commitment to interleukin 4 production by a CD4+ T cell-intrinsic mechanism. 

Phrase: "Genetic regulation of commitment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0017263:genetic regulation [Genetic Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "to interleukin 4 production"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1819457:interleukin-4 production [Organism Function]
   913   C3159141:interleukin production [Organism Function]
   827   C0033268:production [Occupational Activity]
   734   C0021758:Interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1334119:INTERLEUKIN 4 [Gene or Genome]
   734   C1522540:interleukin-4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "by a CD4+ T cell-intrinsic mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.249: J. 

Phrase: "J."
Processing 00000000.tx.250: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.251: Med. 

Phrase: "Med."
Processing 00000000.tx.252: 188:22892299.[Abstract/Free FullText] McIntire, J.J., S.E. 

Phrase: "188"

Phrase: ":"

Phrase: "22892299."

Phrase: "[Abstract/Free FullText"

Phrase: "] McIntire,"

Phrase: "J.J.,"

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.253: Umetsu, O. 

Phrase: "Umetsu,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.254: Akbari, M. 

Phrase: "Akbari,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.255: Potter, V.K. 

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "V.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.256: Kuchroo, G.S. 

Phrase: "Kuchroo,"

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.257: Barsh, G.J. 

Phrase: "Barsh,"

Phrase: "G.J."
Processing 00000000.tx.258: Freeman, D.T. 

Phrase: "Freeman,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.259: Umetsu, and R.H. 

Phrase: "Umetsu,"

Phrase: "and"

Phrase: "R.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.260: DeKruyff. 

Phrase: "DeKruyff."
Processing 00000000.tx.261: 2001. 

Phrase: "2001."
Processing 00000000.tx.262: Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. 

Phrase: "Identification of Tapr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "("

Phrase: "an airway hyperreactivity regulatory locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the linked Tim gene family."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1517488:Gene Family [Gene or Genome]
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   741 E C0241888:Familial [Functional Concept]
   708   C0314613:Linked gene [Genetic Function]
Processing 00000000.tx.263: Nat. 

Phrase: "Nat."
Processing 00000000.tx.264: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.265: 2:11091116.[CrossRef][Medline] Martin, T.R., N.P. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "11091116."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Martin,"

Phrase: "T.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "N.P."
Processing 00000000.tx.266: Gerard, S.J. 

Phrase: "Gerard,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.267: Galli, and J.M. 

Phrase: "Galli,"

Phrase: "and"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: Drazen. 

Phrase: "Drazen."
Processing 00000000.tx.269: 1988. 

Phrase: "1988."
Processing 00000000.tx.270: Pulmonary responses to bronchoconstrictor agonists in the mouse. 

Phrase: "Pulmonary responses to bronchoconstrictor agonists"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.271: J. 

Phrase: "J."
Processing 00000000.tx.272: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.273: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.274: 64:23182323.[Abstract/Free FullText] De Sanctis, G.T., M. 

Phrase: "64"

Phrase: ":"

Phrase: "23182323."

Phrase: "[Abstract/Free FullText"

Phrase: "] De Sanctis,"

Phrase: "G.T.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.275: Merchant, D.R. 

Phrase: "Merchant,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.276: Beier, R.D. 

Phrase: "Beier,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.277: Dredge, J.K. 

Phrase: "Dredge,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.278: Grobholz, T.R. 

Phrase: "Grobholz,"

Phrase: "T.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.279: Martin, E.S. 

Phrase: "Martin,"

Phrase: "E.S."
Processing 00000000.tx.280: Lander, and J.M. 

Phrase: "Lander,"

Phrase: "and"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.281: Drazen. 

Phrase: "Drazen."
Processing 00000000.tx.282: 1995. 

Phrase: "1995."
Processing 00000000.tx.283: Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. 

Phrase: "Quantitative locus analysis of airway hyperresponsiveness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in A/J"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "C57BL/6J mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.284: Nat. 

Phrase: "Nat."
Processing 00000000.tx.285: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.286: 11:150154.[CrossRef][Medline] Hadeiba, H., D.B. 

Phrase: "11"

Phrase: ":"

Phrase: "150154."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hadeiba,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.287: Corry, and R.M. 

Phrase: "Corry,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.288: Locksley. 

Phrase: "Locksley."
Processing 00000000.tx.289: 2000. 

Phrase: "2000."
Processing 00000000.tx.290: Baseline airway hyperreactivity in A/J mice is not mediated by cells of the adaptive immune system. 

Phrase: "Baseline airway hyperreactivity in A/J mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0004096:Airway hyperreactivity [Disease or Syndrome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by cells of the adaptive immune system."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0020962:Immune system [Body System]
   770   C1291764:IMMUNE SYSTEM [Finding]
   744   C0007634:Cells [Cell]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0231193:Adaptive [Functional Concept]
   744   C0439662:Immune [Functional Concept]
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.291: J. 

Phrase: "J."
Processing 00000000.tx.292: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.293: 164:49334940.[Abstract/Free FullText] Ackerman, K.G., H. 

Phrase: "164"

Phrase: ":"

Phrase: "49334940."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ackerman,"

Phrase: "K.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.294: Huang, H. 

Phrase: "Huang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.295: Grasemann, C. 

Phrase: "Grasemann,"

Phrase: "C."
Processing 00000000.tx.296: Puma, J.B. 

Phrase: "Puma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1070653:Puma [Mammal]

Phrase: "J.B."
Processing 00000000.tx.297: Singer, A.E. 

Phrase: "Singer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335076:Singer [Professional or Occupational Group]

Phrase: "A.E."
Processing 00000000.tx.298: Hill, E. 

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "E."
Processing 00000000.tx.299: Lander, J.H. 

Phrase: "Lander,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.300: Nadeau, G.A. 

Phrase: "Nadeau,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.301: Churchill, J.M. 

Phrase: "Churchill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538463:CHURCHILL [Gene or Genome]

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: Drazen, and D.R. 

Phrase: "Drazen,"

Phrase: "and"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.303: Beier. 

Phrase: "Beier."
Processing 00000000.tx.304: 2005. 

Phrase: "2005."
Processing 00000000.tx.305: Interacting loci cause airway hyperresponsiveness. 

Phrase: "Interacting loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "airway hyperresponsiveness."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.306: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.307: Genomics. 

Phrase: "Genomics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]
Processing 00000000.tx.308: In press. 

Phrase: "In press."
Processing 00000000.tx.309: Shinagawa, K., and M. 

Phrase: "Shinagawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.310: Kojima. 

Phrase: "Kojima."
Processing 00000000.tx.311: 2003. 

Phrase: "2003."
Processing 00000000.tx.312: Mouse model of airway remodeling: strain differences. 

Phrase: "Mouse model of airway remodeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C2986594:Mouse Model [Experimental Model of Disease]
   760   C3161035:Model [Intellectual Product]

Phrase: ":"

Phrase: "strain differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.313: Am. 

Phrase: "Am."
Processing 00000000.tx.314: J. 

Phrase: "J."
Processing 00000000.tx.315: Respir. 

Phrase: "Respir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205535:RESPIR [Functional Concept]
Processing 00000000.tx.316: Crit. 

Phrase: "Crit."
Processing 00000000.tx.317: Care Med. 

Phrase: "Care Med."
Processing 00000000.tx.318: 168:959967.[Abstract/Free FullText] Piggott, D.A., S.C. 

Phrase: "168"

Phrase: ":"

Phrase: "959967."

Phrase: "[Abstract/Free FullText"

Phrase: "] Piggott,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "S.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: Eisenbarth, L. 

Phrase: "Eisenbarth,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.320: Xu, S.L. 

Phrase: "Xu,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.321: Constant, J.W. 

Phrase: "Constant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547014:*Constant [Quantitative Concept]
  1000   C1948059:Constant [Qualitative Concept]

Phrase: "J.W."
Processing 00000000.tx.322: Huleatt, C.A. 

Phrase: "Huleatt,"

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.323: Herrick, and K. 

Phrase: "Herrick,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.324: Bottomly. 

Phrase: "Bottomly."
Processing 00000000.tx.325: 2005. 

Phrase: "2005."
Processing 00000000.tx.326: MyD88-dependent induction of allergic Th2 responses to intranasal antigen. 

Phrase: "MyD88-dependent induction of allergic Th2 responses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "to intranasal antigen."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.327: J. 

Phrase: "J."
Processing 00000000.tx.328: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.329: Invest. 

Phrase: "Invest."
Processing 00000000.tx.330: 115:459467.[Abstract/Free FullText] Kheradmand, F., A. 

Phrase: "115"

Phrase: ":"

Phrase: "459467."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kheradmand,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.331: Kiss, J. 

Phrase: "Kiss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233926:kiss [Social Behavior]

Phrase: "J."
Processing 00000000.tx.332: Xu, S.H. 

Phrase: "Xu,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.333: Lee, P.E. 

Phrase: "Lee,"

Phrase: "P.E."
Processing 00000000.tx.334: Kolattukudy, and D.B. 

Phrase: "Kolattukudy,"

Phrase: "and"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.335: Corry. 

Phrase: "Corry."
Processing 00000000.tx.336: 2002. 

Phrase: "2002."
Processing 00000000.tx.337: A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. 

Phrase: "A protease-activated pathway underlying Th cell type 2 activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C1326120:cell activation [Cell Function]
   791   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "allergic lung disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0024115:Lung disease NOS [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.338: J. 

Phrase: "J."
Processing 00000000.tx.339: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.340: 169:59045911.[Abstract/Free FullText] Yu, C.K., and C.L. 

Phrase: "169"

Phrase: ":"

Phrase: "59045911."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.341: Chen. 

Phrase: "Chen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]
Processing 00000000.tx.342: 2003. 

Phrase: "2003."
Processing 00000000.tx.343: Activation of mast cells is essential for development of house dust mite Dermatophagoides farinae-induced allergic airway inflammation in mice. 

Phrase: "Activation of mast cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C1155074:mast cell activation [Cell Function]
   819   C1326120:activation cells [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "essential for development of house dust mite Dermatophagoides farinae-induced allergic airway inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0205224:Essential [Qualitative Concept]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.344: J. 

Phrase: "J."
Processing 00000000.tx.345: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.346: 171:38083815.[Abstract/Free FullText] Ikeda, R.K., M. 

Phrase: "171"

Phrase: ":"

Phrase: "38083815."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "R.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.347: Miller, J. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.348: Nayar, L. 

Phrase: "Nayar,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.349: Walker, J.Y. 

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "J.Y."
Processing 00000000.tx.350: Cho, K. 

Phrase: "Cho,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: McElwain, S. 

Phrase: "McElwain,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.352: McElwain, E. 

Phrase: "McElwain,"

Phrase: "E."
Processing 00000000.tx.353: Raz, and D.H. 

Phrase: "Raz,"

Phrase: "and"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.354: Broide. 

Phrase: "Broide."
Processing 00000000.tx.355: 2003. 

Phrase: "2003."
Processing 00000000.tx.356: Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. 

Phrase: "Accumulation of peribronchial mast cells"

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of ovalbumin allergen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002092:Allergen [Immunologic Factor]
   861   C3274161:Allergen [Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "chronic airway inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0021376:Chronic inflammation [Pathologic Function]
   827   C0021368:Inflammation [Pathologic Function]

Phrase: ":"

Phrase: "modulation by immunostimulatory DNA sequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.357: J. 

Phrase: "J."
Processing 00000000.tx.358: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.359: 171:48604867.[Abstract/Free FullText] Shen, H.H., S.I. 

Phrase: "171"

Phrase: ":"

Phrase: "48604867."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shen,"

Phrase: "H.H.,"

Phrase: "S.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.360: Ochkur, M.P. 

Phrase: "Ochkur,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.361: McGarry, J.R. 

Phrase: "McGarry,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.362: Crosby, E.M. 

Phrase: "Crosby,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: Hines, M.T. 

Phrase: "Hines,"

Phrase: "M.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: Borchers, H. 

Phrase: "Borchers,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.365: Wang, T.L. 

Phrase: "Wang,"

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.366: Biechelle, K.R. 

Phrase: "Biechelle,"

Phrase: "K.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.367: O'Neill, T.L. 

Phrase: "O'Neill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.368: Ansay, et al. 

Phrase: "Ansay,"

Phrase: "et al."
Processing 00000000.tx.369: 2003. 

Phrase: "2003."
Processing 00000000.tx.370: A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. 

Phrase: "A causative relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "exists between eosinophils"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0014467:Eosinophils [Cell]
   790   C0200638:Eosinophils [Laboratory Procedure]
   790   C2987476:Exist [Conceptual Entity]
   706 E C0333930:Eosinophilic [Functional Concept]

Phrase: "and"

Phrase: "the development of allergic pulmonary pathologies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.373: 170:32963305.[Abstract/Free FullText] Mattes, J., M. 

Phrase: "170"

Phrase: ":"

Phrase: "32963305."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mattes,"

Phrase: "J.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.374: Yang, S. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: Mahalingam, J. 

Phrase: "Mahalingam,"

Phrase: "J."
Processing 00000000.tx.376: Kuehr, D.C. 

Phrase: "Kuehr,"

Phrase: "D.C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.377: Webb, L. 

Phrase: "Webb,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.378: Simson, S.P. 

Phrase: "Simson,"

Phrase: "S.P."
Processing 00000000.tx.379: Hogan, A. 

Phrase: "Hogan,"

Phrase: "A."
Processing 00000000.tx.380: Koskinen, A.N. 

Phrase: "Koskinen,"

Phrase: "A.N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1272460:a n [Qualitative Concept]
Processing 00000000.tx.381: McKenzie, L.A. 

Phrase: "McKenzie,"

Phrase: "L.A."
Processing 00000000.tx.382: Dent, et al. 

Phrase: "Dent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880278:DENT [Event]

Phrase: "et al."
Processing 00000000.tx.383: 2002. 

Phrase: "2002."
Processing 00000000.tx.384: Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. 

Phrase: "Intrinsic defect in T cell production of interleukin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1457869:Defect [Functional Concept]
   744   C1861101:DEFECT [Disease or Syndrome]

Phrase: "(an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2:11091116.[CrossRef][Medline] Martin, T.R., N.P. Gerard, S.J. Galli, and J.M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:23182323.[Abstract/Free FullText] De Sanctis, G.T., M. Merchant, D.R. Beier, R.D. Dredge, J.K. Grobholz, T.R. Martin, E.S. Lander, and J.M. Drazen. 1995. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat. Genet. 11:150154.[CrossRef][Medline] Hadeiba, H., D.B. Corry, and R.M. Locksley. 2000. Baseline airway hyperreactivity in A/J mice is not mediated by cells of the adaptive immune system. J. Immunol. 164:49334940.[Abstract/Free FullText] Ackerman, K.G., H. Huang, H. Grasemann, C. Puma, J.B. Singer, A.E. Hill, E. Lander, J.H. Nadeau, G.A. Churchill, J.M. Drazen, and D.R. Beier. 2005. Interacting loci cause airway hyperresponsiveness. Physiol. Genomics. In press. Shinagawa, K., and M. Kojima. 2003. Mouse model of airway remodeling: strain differences. Am. J. Respir. Crit. Care Med. 168:959967.[Abstract/Free FullText] Piggott, D.A., S.C. Eisenbarth, L. Xu, S.L. Constant, J.W. Huleatt, C.A. Herrick, and K. Bottomly. 2005. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J. Clin. Invest. 115:459467.[Abstract/Free FullText] Kheradmand, F., A. Kiss, J. Xu, S.H. Lee, P.E. Kolattukudy, and D.B. Corry. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169:59045911.[Abstract/Free FullText] Yu, C.K., and C.L. Chen. 2003. Activation of mast cells is essential for development of house dust mite Dermatophagoides farinae-induced allergic airway inflammation in mice. J. Immunol. 171:38083815.[Abstract/Free FullText] Ikeda, R.K., M. Miller, J. Nayar, L. Walker, J.Y. Cho, K. McElwain, S. McElwain, E. Raz, and D.H. Broide. 2003. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol. 171:48604867.[Abstract/Free FullText] Shen, H.H., S.I. Ochkur, M.P. McGarry, J.R. Crosby, E.M. Hines, M.T. Borchers, H. Wang, T.L. Biechelle, K.R. O'Neill, T.L. Ansay, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170:32963305.[Abstract/Free FullText] Mattes, J., M. Yang, S. Mahalingam, J. Kuehr, D.C. Webb, L. Simson, S.P. Hogan, A. Koskinen, A.N. McKenzie, L.A. Dent, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   762   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1334121:interleukin-5 [Gene or Genome]
   762   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "eotaxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0250604:Eotaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332676:EOTAXIN [Gene or Genome]
  1000   C1527022:Eotaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "precludes"

Phrase: "the development of eosinophilia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   769   C3159059:eosinophil development [Cell Function]

Phrase: "and"

Phrase: "airways hyperreactivity in experimental asthma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004096:Airway hyperreactivity [Disease or Syndrome]
Processing 00000000.tx.385: J. 

Phrase: "J."
Processing 00000000.tx.386: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.387: Med. 

Phrase: "Med."
Processing 00000000.tx.388: 195:14331444.[Abstract/Free FullText] Humbles, A.A., B. 

Phrase: "195"

Phrase: ":"

Phrase: "14331444."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Humbles"

Phrase: ","

Phrase: "A."

Phrase: "A.,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.389: Lu B, D.S. 

Phrase: "Lu B,"

Phrase: "D.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.390: Friend, S. 

Phrase: "Friend,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079382:friend [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.391: Okinaga, J. 

Phrase: "Okinaga,"

Phrase: "J."
Processing 00000000.tx.392: Lora, A. 

Phrase: "Lora,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443023:Lora [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.393: Al-Garawi, T.R. 

Phrase: "Al-Garawi,"

Phrase: "T.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.394: Martin, N.P. 

Phrase: "Martin,"

Phrase: "N.P."
Processing 00000000.tx.395: Gerard, and C. 

Phrase: "Gerard,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.396: Gerard. 

Phrase: "Gerard."
Processing 00000000.tx.397: 2002. 

Phrase: "2002."
Processing 00000000.tx.398: The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. 

Phrase: "The murine CCR3 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0388437:CCR3 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "regulates"

Phrase: "both the role of eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "mast cells in allergen-induced airway inflammation"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0024880:Mast Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0451297:MAST [Intellectual Product]
   748   C0684269:mast- [Functional Concept]
   748   C1539838:MAST [Gene or Genome]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "hyperresponsiveness."
Processing 00000000.tx.399: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.400: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.401: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.402: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.403: 99:1479-1484.[Abstract/Free FullText] Hamelmann, E., G. 

Phrase: "99"

Phrase: ":"

Phrase: "1479-1484."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamelmann,"

Phrase: "E.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: Cieslewicz, J. 

Phrase: "Cieslewicz,"

Phrase: "J."
Processing 00000000.tx.405: Schwarze, T. 

Phrase: "Schwarze,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.406: Ishizuka, A. 

Phrase: "Ishizuka,"

Phrase: "A."
Processing 00000000.tx.407: Joetham, C. 

Phrase: "Joetham,"

Phrase: "C."
Processing 00000000.tx.408: Heusser, and E.W. 

Phrase: "Heusser,"

Phrase: "and"

Phrase: "E.W."
Processing 00000000.tx.409: Gelfand. 

Phrase: "Gelfand."
Processing 00000000.tx.410: 1999. 

Phrase: "1999."
Processing 00000000.tx.411: Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. 

Phrase: "Anti-interleukin 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021759:Interleukin-5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1334121:interleukin-5 [Gene or Genome]
   901   C1527131:Interleukin 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "but"

Phrase: "not anti-IgE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0051978:anti-IgE [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C2825096:Anti-IgE [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "airway inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "airway hyperresponsiveness."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:Airway, NOS [Medical Device]
   861   C0458827:Airway [Body Part, Organ, or Organ Component]
Processing 00000000.tx.412: Am. 

Phrase: "Am."
Processing 00000000.tx.413: J. 

Phrase: "J."
Processing 00000000.tx.414: Respir. 

Phrase: "Respir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205535:RESPIR [Functional Concept]
Processing 00000000.tx.415: Crit. 

Phrase: "Crit."
Processing 00000000.tx.416: Care Med. 

Phrase: "Care Med."
Processing 00000000.tx.417: 160:934941.[Abstract/Free FullText] Lee, J.J., D. 

Phrase: "160"

Phrase: ":"

Phrase: "934941."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "J.J.,"

Phrase: "D."
Processing 00000000.tx.418: Dimina, M.P. 

Phrase: "Dimina,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.419: Macias, S.I. 

Phrase: "Macias,"

Phrase: "S.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: Ochkur, M.P. 

Phrase: "Ochkur,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.421: McGarry, K.R. 

Phrase: "McGarry,"

Phrase: "K.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.422: O'Neill, C. 

Phrase: "O'Neill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.423: Protheroe, R. 

Phrase: "Protheroe,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.424: Pero, T. 

Phrase: "Pero,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1227755:Pero [Eukaryote]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.425: Nguyen, S.A. 

Phrase: "Nguyen,"

Phrase: "S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.426: Cormier, E. 

Phrase: "Cormier,"

Phrase: "E."
Processing 00000000.tx.427: Lenkiewicz, D. 

Phrase: "Lenkiewicz,"

Phrase: "D."
Processing 00000000.tx.428: Colbert D, L. 

Phrase: "Colbert D,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.429: Rinaldi, S.J. 

Phrase: "Rinaldi,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.430: Ackerman, C.G. 

Phrase: "Ackerman,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.431: Irvin CG, and N.A. 

Phrase: "Irvin CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.432: Lee. 

Phrase: "Lee."
Processing 00000000.tx.433: 2004. 

Phrase: "2004."
Processing 00000000.tx.434: Defining a link with asthma in mice congenitally deficient in eosinophils. 

Phrase: "Defining"

Phrase: "a link with asthma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "congenitally deficient in eosinophils."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011155:Deficient [Functional Concept]
   770   C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.435: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.436: 305:1773-1776.[Abstract/Free FullText] Humbles, A.A., C.M. 

Phrase: "305"

Phrase: ":"

Phrase: "1773-1776."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Humbles"

Phrase: ","

Phrase: "A."

Phrase: "A.,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: Lloyd, S.J. 

Phrase: "Lloyd,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.438: McMillan, D.S. 

Phrase: "McMillan,"

Phrase: "D.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.439: Friend, G. 

Phrase: "Friend,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079382:friend [Population Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.440: Xanthou, E.E. 

Phrase: "Xanthou,"

Phrase: "E.E."
Processing 00000000.tx.441: McKenna, S. 

Phrase: "McKenna,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.442: Ghiran, N.P. 

Phrase: "Ghiran,"

Phrase: "N.P."
Processing 00000000.tx.443: Gerard, C. 

Phrase: "Gerard,"

Phrase: "C."
Processing 00000000.tx.444: Yu, S.H. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.445: Orkin, and C. 

Phrase: "Orkin,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.446: Gerard. 

Phrase: "Gerard."
Processing 00000000.tx.447: 2004. 

Phrase: "2004."
Processing 00000000.tx.448: A critical role for eosinophils in allergic airways remodeling. 

Phrase: "A critical role for eosinophils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in allergic airways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178987:airways [Medical Device]
   861   C0458827:Airways [Body Part, Organ, or Organ Component]

Phrase: "remodeling."
Processing 00000000.tx.449: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.450: 305:17761779.[Abstract/Free FullText] Kobayashi, T., K. 

Phrase: "305"

Phrase: ":"

Phrase: "17761779."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kobayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.451: Iijima, and H. 

Phrase: "Iijima,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.452: Kita. 

Phrase: "Kita."
Processing 00000000.tx.453: 2003. 

Phrase: "2003."
Processing 00000000.tx.454: Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. 

Phrase: "Marked airway eosinophilia"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0014457:Eosinophilia [Disease or Syndrome]
   827   C1306759:Eosinophilia [Disease or Syndrome]
   827   C1636667:Eosinophilia [Disease or Syndrome]
   827   C2240374:Eosinophilia [Finding]
   755 E C0333930:Eosinophilic [Functional Concept]
   727 E C0014467:Eosinophils [Cell]
   727 E C0200638:Eosinophils [Laboratory Procedure]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "development of airway hyper-responsiveness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "during an allergic response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020517:allergic response [Pathologic Function]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "in IL-5 transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.455: J. 

Phrase: "J."
Processing 00000000.tx.456: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.457: 170:57565763.[Abstract/Free FullText] Cho, J.Y., M. 

Phrase: "170"

Phrase: ":"

Phrase: "57565763."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cho,"

Phrase: "J.Y.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.458: Miller, K.J. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "K.J."
Processing 00000000.tx.459: Baek, J.W. 

Phrase: "Baek,"

Phrase: "J.W."
Processing 00000000.tx.460: Han, J. 

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "J."
Processing 00000000.tx.461: Nayar, S.Y. 

Phrase: "Nayar,"

Phrase: "S."

Phrase: "Y."
Processing 00000000.tx.462: Lee, K. 

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.463: McElwain, S. 

Phrase: "McElwain,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: McElwain, S. 

Phrase: "McElwain,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.465: Friedman, and D.H. 

Phrase: "Friedman,"

Phrase: "and"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.466: Broide. 

Phrase: "Broide."
Processing 00000000.tx.467: 2004. 

Phrase: "2004."
Processing 00000000.tx.468: Inhibition of airway remodeling in IL-5-deficient mice. 

Phrase: "Inhibition of airway remodeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in IL-5-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.469: J. 

Phrase: "J."
Processing 00000000.tx.470: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.471: Invest. 

Phrase: "Invest."
Processing 00000000.tx.472: 113:551560.[Abstract/Free FullText] Henderson, W.R., Jr., L.O. 

Phrase: "113"

Phrase: ":"

Phrase: "551560."

Phrase: "[Abstract/Free FullText"

Phrase: "] Henderson,"

Phrase: "W.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "L.O."
Processing 00000000.tx.473: Tang, S.J. 

Phrase: "Tang,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.474: Chu, S.M. 

Phrase: "Chu,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: Tsao, G.K. 

Phrase: "Tsao,"

Phrase: "G.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.476: Chiang, F. 

Phrase: "Chiang,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.477: Jones, M. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: Jonas, C. 

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "C."
Processing 00000000.tx.479: Pae, H. 

Phrase: "Pae,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.480: Wang, and E.Y. 

Phrase: "Wang,"

Phrase: "and"

Phrase: "E.Y."
Processing 00000000.tx.481: Chi. 

Phrase: "Chi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]
Processing 00000000.tx.482: 2002. 

Phrase: "2002."
Processing 00000000.tx.483: A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. 

Phrase: "A role for cysteinyl leukotrienes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in airway remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2717792:Airway Remodeling [Finding]

Phrase: "in a mouse asthma model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.484: Am. 

Phrase: "Am."
Processing 00000000.tx.485: J. 

Phrase: "J."
Processing 00000000.tx.486: Respir. 

Phrase: "Respir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205535:RESPIR [Functional Concept]
Processing 00000000.tx.487: Crit. 

Phrase: "Crit."
Processing 00000000.tx.488: Care Med. 

Phrase: "Care Med."
Processing 00000000.tx.489: 165:108116.[Abstract/Free FullText] Taube, C., X. 

Phrase: "165"

Phrase: ":"

Phrase: "108116."

Phrase: "[Abstract/Free FullText"

Phrase: "] Taube,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "X."
Processing 00000000.tx.490: Wei X, C.H. 

Phrase: "Wei X,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.491: Swasey, A. 

Phrase: "Swasey,"

Phrase: "A."
Processing 00000000.tx.492: Joetham, S. 

Phrase: "Joetham,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: Zarini, T. 

Phrase: "Zarini,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.494: Lively, K. 

Phrase: "Lively, K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.495: Takeda, J. 

Phrase: "Takeda,"

Phrase: "J."
Processing 00000000.tx.496: Loader, N. 

Phrase: "Loader,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0403151:Loader [Professional or Occupational Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.497: Miyahara, T. 

Phrase: "Miyahara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.498: Kodama, L.D. 

Phrase: "Kodama,"

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.499: Shultz, D.D. 

Phrase: "Shultz,"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.500: Donaldson, E.H. 

Phrase: "Donaldson,"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.501: Hamelmann, A. 

Phrase: "Hamelmann,"

Phrase: "A."
Processing 00000000.tx.502: Dakhama, and E.W. 

Phrase: "Dakhama,"

Phrase: "and"

Phrase: "E.W."
Processing 00000000.tx.503: Gelfand. 

Phrase: "Gelfand."
Processing 00000000.tx.504: 2004. 

Phrase: "2004."
Processing 00000000.tx.505: Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. 

Phrase: "Mast cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0024880:Mast Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0451297:MAST [Intellectual Product]
   861   C0684269:mast- [Functional Concept]
   861   C1539838:MAST [Gene or Genome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Fc epsilon RI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162825:Fc epsilon RI [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0035487:RI [Geographic Area]

Phrase: "and"

Phrase: "IL-13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:Interleukin-13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522557:Interleukin 13 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "required for development of airway hyperresponsiveness"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0178987:Airway, NOS [Medical Device]
   753   C0243107:development [Physiologic Function]
   753   C0458827:Airway [Body Part, Organ, or Organ Component]
   753   C0678723:Development [Organism Function]
   753   C1514873:Required [Functional Concept]
   753   C1527148:Development [Functional Concept]

Phrase: "after aerosolized allergen exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0238614:ALLERGEN EXPOSURE [Finding]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of adjuvant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
  1000   C0001552:Adjuvant [Chemical Viewed Functionally]
  1000   C1522673:Adjuvant [Functional Concept]
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.508: 172:6398-6406.[Abstract/Free FullText] Martin, T.R., T. 

Phrase: "172"

Phrase: ":"

Phrase: "6398-6406."

Phrase: "[Abstract/Free FullText"

Phrase: "] Martin,"

Phrase: "T.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.509: Takeishi, H.R. 

Phrase: "Takeishi,"

Phrase: "H.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.510: Katz, K.F. 

Phrase: "Katz,"

Phrase: "K.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.511: Austen, J.M. 

Phrase: "Austen,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.512: Drazen, and S.J. 

Phrase: "Drazen,"

Phrase: "and S.J."
Processing 00000000.tx.513: Galli. 

Phrase: "Galli."
Processing 00000000.tx.514: 1993. 

Phrase: "1993."
Processing 00000000.tx.515: Mast cell activation enhances airway responsiveness to methacholine in the mouse. 

Phrase: "Mast cell activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155074:mast cell activation [Cell Function]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0024880:mast cell [Cell]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "airway responsiveness to methacholine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178987:Airway, NOS [Medical Device]
   770   C0458827:Airway [Body Part, Organ, or Organ Component]

Phrase: "in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.516: J. 

Phrase: "J."
Processing 00000000.tx.517: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.518: Invest. 

Phrase: "Invest."
Processing 00000000.tx.519: 91:11761182.[Medline] Mayr, S.I., R.I. 

Phrase: "91"

Phrase: ":"

Phrase: "11761182."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mayr,"

Phrase: "S.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "R.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.520: Zuberi, M. 

Phrase: "Zuberi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.521: Zhang, J. de Sousa-Hitzler, K. 

Phrase: "Zhang,"

Phrase: "J. de Sousa-Hitzler,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.522: Ngo, Y. 

Phrase: "Ngo,"

Phrase: "Y."
Processing 00000000.tx.523: Kuwabara, L. 

Phrase: "Kuwabara,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.524: Yu, W.P. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "W.P."
Processing 00000000.tx.525: Fung-Leung, F.T. 

Phrase: "Fung-Leung,"

Phrase: "F.T."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.526: Liu. 

Phrase: "Liu."
Processing 00000000.tx.527: 2002. 

Phrase: "2002."
Processing 00000000.tx.528: IgE-dependent mast cell activation potentiates airway responses in murine asthma models. 

Phrase: "IgE-dependent mast cell activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1155074:mast cell activation [Cell Function]
   840   C1326120:cell activation [Cell Function]
   804   C1879547:Activation [Activity]

Phrase: "potentiates"

Phrase: "airway responses in murine asthma models."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]
Processing 00000000.tx.529: J. 

Phrase: "J."
Processing 00000000.tx.530: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.531: 169:20612068.[Abstract/Free FullText] Ichinose, M., and P.J. 

Phrase: "169"

Phrase: ":"

Phrase: "20612068."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ichinose,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "P.J."
Processing 00000000.tx.532: Barnes. 

Phrase: "Barnes."
Processing 00000000.tx.533: 2004. 

Phrase: "2004."
Processing 00000000.tx.534: Cytokine-directed therapy in asthma. 

Phrase: "Cytokine-directed therapy in asthma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0199974:Cytokine therapy [Therapeutic or Preventive Procedure]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C1363945:Therapy [Finding]
Processing 00000000.tx.535: Curr. 

Phrase: "Curr."
Processing 00000000.tx.536: Drug Targets  Inflamm. 

Phrase: "Drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "Targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "Inflamm."
Processing 00000000.tx.537: Allergy. 

Phrase: "Allergy."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0002111:Allergy [Biomedical Occupation or Discipline]
  1000   C0020517:Allergy [Pathologic Function]
  1000   C0489531:allergy [Finding]
  1000   C1314973:ALLERGY [Clinical Attribute]
  1000   C3539909:Allergy [Disease or Syndrome]
   928 E C0700624:Allergic [Functional Concept]
Processing 00000000.tx.538: 3:263269.[CrossRef][Medline]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "263269."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

